{"path":"200 FILES/202 PDF/Adult medical emergencies/Diabetes mellitus/Management of diabetes mellitus in hospitalized patients - UpToDate.pdf","text":"O f f ic ia l r e p r in t f r o m U p To D a t e w w w .u p t o d a t e .c o m © 2 0 2 4 U p To D a t e , I n c . a n d / o r it s a f f ilia t e s . A ll R ig h t s R e s e r v e d . M a n a g e m e n t o f d ia b e t e s m e llit u s in h o s p it a liz e d p a t ie n t s I N T R O D U C T I O N P a t ie n t s w it h t y p e 1 o r t y p e 2 d ia b e t e s m e llit us a r e f r e q u e ntly a d m it t e d t o a ho s p it a l, usua lly f o r t r e a t m e n t o f c o n d it io n s o t h e r t h a n t he d ia b e t e s [1 ,2 ]. I n o n e s t u d y , 2 5 p e r c e n t o f p a t ie nts w it h t y p e 1 d ia b e t e s a n d 3 0 p e r c e n t w it h t y p e 2 d ia b e t e s ha d a ho s p it a l a d m is s io n d ur ing o ne y e a r ; p a t ie n t s w it h h ig h e r v a lu e s f o r g ly c a t e d he m o g lo b in (A 1 C ) w e r e a t hig he s t r is k f o r a d m is s io n [2 ]. T h e p r e v a le n c e o f d ia b e t e s r is e s w it h inc r e a s ing a g e , a s d o e s t he p r e v a le nc e o f o t he r d is e a s e s ; b o t h f a c t o r s in c r e a s e t h e lik e liho o d t ha t a n o ld e r p e r s o n a d m it t e d t o a ho s p it a l w ill h a v e d ia b e t e s . T h e t r e a t m e n t o f p a t ie n t s w it h d ia b e t e s w ho a r e a d m it t e d t o t he g e n e r a l m e d ic a l w a r d s o f t he h o s p it a l f o r a p r o c e d u r e o r in t e r c u r r e nt illne s s is r e v ie w e d he r e . T he t r e a t m e nt o f h y p e r g ly c e m ia in c r it ic a lly ill p a t ie nts, t he p e r io p e r a t iv e m a na g e m e nt o f d ia b e t e s , a nd t he t r e a t m e n t o f c o m p lic a t io n s o f t h e d ia b e t e s it s e lf, s uc h a s d ia b e t ic k e t o a c id o s is , a r e d is c usse d s e p a r a t e ly . (S e e \" G ly c e m ic c o n t r o l in c r it ic a lly ill a d u lt a nd p e d ia t r ic p a t ie nts\" a n d \" P e r io p e r a t iv e m a n a g e m e n t o f b lo o d g lu c o s e in a d ult s w it h d ia b e t e s m e llit us\" a n d \" D ia b e t ic k e t o a c id o s is a n d h y p e r o s m o la r h y p e r g ly c e m ic s t a t e in a d u lt s : T r e a t m e n t \" a n d \" H y p o g ly c e m ia in a d u lt s w it h d ia b e t e s m e llit u s \" .) G O A L S I N T H E H O S P I TA L S ET T I N G ® \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : S ilv io E I n z u c c h i, M D \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : D a v id M N a t h a n , M D \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 \u0000 : K a t y a R u b in o w , M D A ll t o p ic s a r e u p d a t e d a s n e w e v id e n c e b e c o m e s a v a ila b le a n d o u r p e e r r e v ie w p r o c e s s is c o m p le t e . L it e r a t u r e r e v ie w c u r r e n t t h r o u g h : J a n 2 0 2 4 . T h is t o p ic la s t u p d a t e d : J a n 0 4 , 2 0 2 4 . T h e m a in g o a ls in p a t ie n t s w it h d ia b e t e s ne e d in g ho s p it a liz a t io n a r e t o m inim iz e d is r up t io n o f t h e m e t a b o lic s t a t e , p r e v e n t a d v e r s e g ly c e m ic e v e nts (e s p e c ia lly hy p o g ly c e m ia ), r e t ur n t he p a t ie n t t o a s t a b le g ly c e m ic b a la n c e a s q u ic k ly a s p o s s ib le , a nd e nsur e a s m o o t h t r a nsit io n t o o u t p a t ie n t c a r e . T h e s e g o a ls a r e n o t a lw a y s e a s y t o a c hie v e . O n t he o ne ha nd , t he s t r e s s o f t he a c u t e illn e s s t e n d s t o r a is e b lo o d g luc o s e c o nc e ntr a t io ns. O n t he o t he r ha nd , t he a no r e x ia t ha t o f t e n a c c o m p a n ie s illn e s s o r t h e n e e d f o r f a s t ing b e f o r e p r o c e d u r e s t e nd t o d o t he o p p o s it e . B e c a u s e t h e n e t e f f e c t o f t h e s e c o u n t e r v a iling f o r c e s is no t e a s ily p r e d ic t a b le in a g iv e n p a t ie nt, t h e t a r g e t b lo o d g lu c o s e c o n c e n t r a t io n s ho uld g e n e r a lly b e hig h e r t ha n in t he o utp a t ie nt s e t t in g . U n c e r t a in t y r e g a r d in g g o a l b lo o d g luc o s e c o nc e ntr a t io n is c o m p o und e d b y t he p a uc it y o f hig h- q u a lit y c o n t r o lle d t r ia ls o n t h e b e n e f it s a nd r is k s o f \" lo o s e \" o r \" t ig h t \" g ly c e m ic m a na g e m e nt in h o s p it a liz e d p a t ie n t s , w it h t h e e x c e p t io n o f p a t ie nts w ho a r e c r it ic a lly ill. (S e e \" G ly c e m ic c o n t r o l in c r it ic a lly ill a d u lt a n d p e d ia t r ic p a t ie nts\" .) I n g e n e r a l, t h e g o a ls a r e t o : C r it ic a l t o a c h ie v in g t h e s e g o a ls is t he f r e q u e nt m e a s ur e m e n t o f g lu c o s e , o f t e n in c a p illa r y b lo o d , w it h a m e t h o d t h a t is k n o w n t o b e r e lia b le . (S e e \" G lu c o s e m o n it o r in g in t h e a m b u la t o r y m a n a g e m e n t o f n o n p r e g n a n t a d u lt s w it h d ia b e t e s m e llit us\" , s e c t io n o n 'B G M s y s t e m s '.) A v o i d a n c e o f h y p o g l y c e m i a  — H y p o g ly c e m ia s h o u ld b e a v o id e d if a t a ll p o s s ib le . M e a s ur e s t o r e d u c e t h e r is k o f h y p o g ly c e m ia inc lud e : A v o id h y p o g ly c e m ia● A v o id s e v e r e h y p e r g ly c e m ia , v o lu m e d e p le t io n, a nd e le c t r o ly t e lo s s e s● E n s u r e a d e q u a t e n u t r it io n● A s s e s s p a t ie n t e d u c a t io n a l n e e d s a n d a d d r e s s inf o r m a t io na l d e f ic ie nc ie s● E n s u r e a p p r o p r ia t e g lu c o s e m a n a g e m e n t up o n d is c ha r g e until p a t ie nt c a n b e s e e n b y t he c lin ic ia n m a n a g in g h is o r h e r d ia b e t e s a s a n o utp a t ie nt ● A d e q u a t e r e d u c t io n in a n t ih y p e r g ly c e m ic t he r a p y w he n c a lo r ic inta k e is s t o p p e d o r r e d u c e d . ● A v o id a n c e o f s t a n d a r d \"s lid in g s c a le \" o f insulin w it ho ut c o nsid e r a t io n o f t he p a t ie nt 's s p e c if ic c ir c u m s t a n c e s . ● A v o id a n c e o f o v e r ly a g g r e s s iv e a t t e m p t s t o p r o v id e \" t ig h t \" g ly c e m ic m a na g e m e nt in t r a o p e r a t iv e ly [3 ] o r w it h in t e n s iv e in s u lin t h e r a p y in c r it ic a lly ill p a t ie nts [4 ]. (S e e \" G ly c e m ic c o n t r o l in c r it ic a lly ill a d u lt a nd p e d ia t r ic p a t ie nts\" .) ● A lt h o u g h r e la t iv e ly b r ie f a n d m ild hy p o g ly c e m ia d o e s no t usua lly ha v e c linic a lly s ig nif ic a nt s e q u e la e , h o s p it a liz e d p a t ie n t s a r e p a r t ic ula r ly v ulne r a b le t o s e v e r e , p r o lo ng e d hy p o g ly c e m ia s in c e t h e y m a y b e u n a b le t o s e n s e o r r e s p o n d t o t he e a r ly w a r ning s ig ns a nd s y m p t o m s o f lo w b lo o d g lu c o s e . H y p o g ly c e m ia (ie , s e r u m g lu c o s e c o nc e ntr a t io n < 7 0 m g / d L [3 .9 m m o l/ L ]) c a n b e ha r m f ul d ue t o t h e e f f e c t s o f c o u n t e r r e g u la t o r y h o r m o n e s , e s p e c ia lly c a t e c ho la m in e s , w hic h m a y p o s s ib ly in d u c e a r r h y t h m ia s a n d o t h e r c a r d ia c e v e nts. T his is e s p e c ia lly t r ue in o ld e r a d ult s a nd t ho s e w it h p r e e x is t in g is c h e m ic h e a r t d is e a s e . I f t he b lo o d g lu c o s e f a lls t o o r b e lo w 5 4 m g / d L (3 .0 m m o l/ L , t e r m e d \"c lin ic a lly s ig n if ic a nt hy p o g ly c e m ia \" ), c o g n it iv e d e f ic it s m a y a ls o e nsue , w hic h c a n le a d t o f a lls o r a s p ir a t io n . I n a r e t r o s p e c t iv e c o ho r t s t ud y o f o v e r 2 5 0 0 p a t ie nts w it h d ia b e t e s h o s p it a liz e d in t h e g e n e r a l w a r d s , inp a t ie nt m o r t a lit y w a s s ig nif ic a ntly hig he r f o r p a t ie n t s w it h a t le a s t o n e h y p o g ly c e m ic (≤5 0 m g / d L [2 .8 m m o l/ L ]) e p is o d e [5 ]. A v o i d a n c e o f h y p e r g l y c e m i a  — S e r io u s h y p e r g ly c e m ia s h o u ld b e a v o id e d (s e e 'P r e v e n t io n a n d t r e a t m e n t o f h y p e r g ly c e m ia ' b e lo w ). H y p e r g ly c e m ia c a n le a d t o v o lum e a nd e le c t r o ly t e d is t u r b a n c e s m e d ia t e d b y o s m o t ic d iu r e s is a nd m a y a ls o r e s ult in c a lo r ic a nd p r o t e in lo s s e s in u n d e r - in s u lin iz e d p a t ie n t s . W h e t h e r o r n o t h y p e r g ly c e m ia im p o s e s a n ind e p e nd e n t r is k f o r inf e c t io n is a c o ntr o v e r s ia l is s u e . I t is a lo n g s t a n d in g c lin ic a l o b s e r v a t io n t ha t p a t ie nts w it h d ia b e t e s a r e m o r e s usc e p t ib le t o in f e c t io n [6 ]. F u r t h e r m o r e , im m u n e a n d n e u t r o p h il f u nc t io n a r e im p a ir e d d u r ing m a r k e d h y p e r g ly c e m ia . M o s t o f t h e s t u d ie s a d d r e s s ing t his q u e s t io n ha v e f o c use d o n t he r is k o f p o s t o p e r a t iv e in f e c t io n (a n d e s p e c ia lly s t e r na l w o und inf e c t io n) f o llo w ing c o r o na r y a r t e r y b y p a s s g r a f t in g (C A B G ), a n d t h e y s ho w m ix e d r e s ult s . T his is s ue is d is c usse d in d e t a il e ls e w he r e . (S e e \" S u s c e p t ib ilit y t o in f e c t io n s in p e r s o n s w it h d ia b e t e s m e llit us\" , s e c t io n o n 'R is k o f in f e c t io n '.) G l y c e m i c t a r g e t s  — A lt h o u g h t h e r e a r e a d e q u a t e e x p e r im e n t a l a nd o b s e r v a t io na l d a t a t o r e c o m m e n d a v o id a n c e o f m a r k e d h y p e r g ly c e m ia in p a t ie nts w it h o r a t r is k f o r inf e c t io n, t he p r e c is e g ly c e m ic t a r g e t o r t h r e s h o ld f o r no nc r it ic a lly ill o r c r it ic a lly ill p a t ie nts w it h p r e e x is t ing d ia b e t e s m e llit u s h a s n o t b e e n f ir m ly e s t a b lis he d [6 - 8 ]. I n t h e a b s e n c e o f d a t a f r o m c lin ic a l t r ia ls , t h e o p t im a l b lo o d g lu c o s e g o a l f o r ho s p it a liz e d p a t ie nts c a n o nly b e a p p r o x im a t e . N o n c r i t i c a l l y i l l  — F o r m o s t n o n c r it ic a lly ill h o s p it a liz e d p a t ie nts w it h d ia b e t e s , w e s ug g e s t a p r e p r a n d ia l b lo o d g lu c o s e t a r g e t < 1 4 0 m g / d L (7 .8 m m o l/ L ) w it h a ll r a nd o m g luc o s e v a lue s < 1 8 0 m g / d L (1 0 m m o l/ L ). T h e s e t a r g e t s a r e s im ila r t o t h o s e f r o m a c o nse nsus s t a t e m e n t b y t he A m e r ic a n D ia b e t e s A s s o c ia t io n (A D A ; 1 4 0 t o 1 8 0 m g / d L ) a nd t he c linic a l p r a c t ic e g u id e lin e o f t he E nd o c r ine S o c ie t y [9 ,1 0 ]. T h e A D A h a s n o t s t ip u la t e d a n y d if f e r e nc e s in t a r g e t g lu c o s e v a lue s b a s e d o n t he t im ing o f t h e m e a s u r e m e n t s , s u c h a s p r e p r a nd ia l v e r s us p o s t p r a nd ia l. T he E nd o c r ine S o c ie t y r e c o m m e n d s p r e - m e a l t a r g e t s < 1 4 0 m g / d L a nd \"r a nd o m \" g lu c o s e le v e ls < 1 8 0 m g / d L . M o r e s t r in g e n t g o a ls m a y b e a p p r o p r ia t e f o r s t a b le p a t ie nts w it h p r e v io us g o o d g ly c e m ic m a n a g e m e n t , a n d t h e g o a l s h o u ld b e s e t s o m e w h a t hig h e r f o r o ld e r p a t ie nts a nd t ho s e w it h s e v e r e c o m o r b id it ie s w h e r e t h e h e ig hte ne d r is k o f hy p o g ly c e m ia m a y o utw e ig h a ny p o t e ntia l b e n e f it . A r e a s o n a b le g ly c e m ic g o a l t o a v o id hy p o g ly c e m ia is t o a c hie v e f a s t ing b lo o d g luc o s e c o n c e n t r a t io n s n o lo w e r t h a n 9 0 t o 1 0 0 m g / d L (5 .0 t o 5 .6 m m o l/ L ); t his w ill usua lly p r o v id e a n a d e q u a t e \"c u s h io n \" in c a s e t h e c o n c e ntr a t io n f a lls f u r t he r a s t he p a t ie nt 's illne s s im p r o v e s . I n g e n e r a l, a ll g lu c o s e le v e ls s h o u ld b e k e p t b e lo w t he 1 8 0 m g / d L (1 0 .0 m m o l/ L ) r a ng e t o a v o id f u r t h e r e s c a la t io n s , w h ic h m a y le a d t o d e h y d r a t io n, g ly c o s ur ia , c a lo r ic lo s s , a nd inc r e a s e d r is k o f in f e c t io n o r h y p e r g ly c e m ic e m e r g e n c ie s . C r i t i c a l l y i l l  — F o r t h e m a jo r it y o f c r it ic a lly ill p a t ie nts, w e a g r e e w it h A D A r e c o m m e nd a t io ns f o r a b lo o d g lu c o s e t a r g e t o f 1 4 0 t o 1 8 0 m g / d L (7 .8 t o 1 0 .0 m m o l/ L ) [1 0 ]. A c h ie v in g t h is g o a l w ill u s u a lly r e q u ir e a n in s u lin in f u s io n , w hic h s ho uld b e init ia t e d f o r p e r s is t e nt hy p e r g ly c e m ia ≥1 8 0 m g / d L (1 0 .0 m m o l/ L ). T h e d a t a s u p p o r t ing t he s e g ly c e m ic g o a ls a r e p r e s e nte d s e p a r a t e ly . (S e e \" G ly c e m ic c o n t r o l in c r it ic a lly ill a d u lt a nd p e d ia t r ic p a t ie nts\" .) A c u t e M I  — T h e r e is in c r e a s in g e v id e n c e t h a t s ub o p t im a l g ly c e m ic m a na g e m e nt in p a t ie nts w it h d ia b e t e s (o r s t r e s s - in d u c e d h y p e r g ly c e m ia in p a t ie nts w it ho ut d ia b e t e s ) is a s s o c ia t e d w it h w o r s e o u t c o m e s a f t e r a c u t e m y o c a r d ia l inf a r c t io n (M I ) a nd t ha t b e t t e r g ly c e m ic m a na g e m e nt m a y b e b e n e f ic ia l in s o m e in d iv id u a ls . P R EV EN T I O N A N D T R EA T M EN T O F H Y P ER G L Y C EM I A T r e a t m e n t o f h y p e r g ly c e m ia in h o s p it a liz e d p a t ie nts d e p e nd s up o n t he t y p e o f d ia b e t e s , t he p a t ie n t 's c u r r e n t b lo o d g lu c o s e c o nc e ntr a t io ns, p r io r t r e a t m e n t , t he c linic a lly a s s e s s e d s e v e r it y o f illn e s s , a n d t h e e x p e c t e d c a lo r ic inta k e d u r ing t he a c ute e p is o d e ( a lg o r it h m 1 a n d a lg o r it h m 2 ) [1 ,1 1 - 1 3 ]. I n t h e a b s e n c e o f la r g e c o n t r o lle d c linic a l t r ia ls r e g a r d in g ho w b e s t t o m a na g e t he inp a t ie nt w it h d ia b e t e s , t h e m a n a g e m e n t a p p r o a c h o utline d b e lo w is b a s e d p r im a r ily up o n c linic a l e x p e r t is e . B l o o d g l u c o s e m o n i t o r i n g  — A t t h e t im e o f a d m is s io n o r b e f o r e a n o utp a t ie nt p r o c e d u r e o r t r e a t m e n t , b lo o d g lu c o s e s h o u ld b e m e a s ur e d a nd t he r e s ult k no w n. I n a d d it io n, g luc o s e m o n it o r in g s h o u ld b e c o n t in u e d s o t ha t a p p r o p r ia t e a c t io n m a y b e t a k e n. F r e q u e n c y o f m o n i t o r i n g – T h e f r e q u e n c y o f m e a s u r e m e n t d e p e nd s up o n t he p a t ie nt 's s t a t u s , t h e r e s u lt s o f e a r lie r m e a s u r e m e n t s , a nd t he s t e p s t a k e n a s a r e s ult o f t ho s e m e a s u r e m e n t s . I m p o r t a n t ly , in p a t ie nts w it h d ia b e t e s (o r hy p e r g ly c e m ia ) w ho a r e e a t ing , t h e b lo o d g lu c o s e m o n it o r in g s h o u ld o c c ur just b e f o r e t he m e a l. I n t ho s e w ho a r e r e c e iv in g n o t h in g b y m o u t h , o r r e c e iv ing c o ntinuo us t ub e f e e d s o r t o t a l p a r e n t e r a l n u t r it io n , t h e b lo o d g lu c o s e m o n it o r in g s h o uld o c c ur a t r e g u la r, f ix e d inte r v a ls , usua lly e v e r y s ix h o u r s . ● M o d e o f m o n i t o r i n g – I n h o s p it a liz e d p a t ie n t s , b lo o d g luc o s e m o n it o r ing is t y p ic a lly p e r f o r m e d t h r o u g h c o n v e n t io n a l c a p illa r y g lu c o s e t e s t ing w it h a f in g e r s t ic k a nd g luc o s e m e t e r. A lt h o u g h c o n t in u o u s g lu c o s e m o n it o r ing (C G M ) is no t g e n e r a lly r e c o m m e nd e d f o r t h e in p a t ie n t o r c r it ic a l c a r e s e t t in g , it ha s b e e n use d in inp a t ie nt lo c a t io ns m o r e f r e q u e n t ly s in c e t h e o n s e t o f t h e c o r o na v ir us 2 0 1 9 (C O V I D - 1 9 ) p a nd e m ic . (S e e \" C O V I D - 1 9 : I s s u e s r e la t e d t o d ia b e t e s m e llit u s in a d u lt s \" .) ● C lin ic a l t r ia l d a t a g e n e r a lly h a v e s ho w n s m a ll a nd p e r ha p s no t c linic a lly m e a ning f ul g ly c e m ic b e n e f it s w it h C G M c o m p a r e d w it h t r a d it io na l g lu c o s e m o n it o r ing [1 4 ,1 5 ]. A s a n e x a m p le , in a t r ia l in 1 8 5 h o s p it a liz e d a d u lt s w it h t y p e 1 a nd t y p e 2 d ia b e t e s o n g e ne r a l m e d ic in e a n d s u r g e r y s e r v ic e s , t im e s p e n t in t a r g e t g lu c o s e r a ng e (7 0 t o 1 8 0 m g / d L [3 .9 t o 1 0 m m o l/ L ]) a n d m e a n d a ily g lu c o s e d id no t d if f e r b e t w e e n p a r t ic ip a nts r a nd o m ly a s s ig n e d t o g lu c o s e m o n it o r in g w it h C G M a nd t ho s e w ho und e r w e nt c o nv e ntio na l m o n it o r in g [1 4 ]. T h e s a m e s t u d y s h o w e d a s m a ll r e d u c t io n in hy p o g ly c e m ia r e o c c ur r e nc e w it h C G M c o m p a r e d w it h c o n v e n t io na l m o n it o r ing , b u t t he o v e r a ll r a t e s w e r e v e r y lo w [1 4 ]. C G M m a y b e u s e f u l in s e le c t e d in p a t ie nts, s uc h a s t ho s e f o r w ho m c lo s e c o nta c t w it h in p a t ie n t p r o v id e r s s h o u ld b e m in im iz e d (e g , C O V I D - 1 9 o r o t he r hig h ly t r a nsm is s ib le in f e c t io n ) o r p o s s ib ly , in p a t ie n t s a t hig h r is k f o r hy p o g ly c e m ia [1 4 ,1 6 ]. H o s p it a ls t h a t u s e t h e s e d e v ic e s r o u t in e ly m u s t p r o v id e p r o p e r p e r s o nne l t r a ining a nd r e s o ur c e s f o r s a f e a p p lic a t io n o f C G M [1 7 ]. I t is c e r t a in ly r e a s o n a b le f o r p a t ie n t s using C G M a t ho m e t o c o ntinue w e a r ing t he s e d e v ic e s w h ile h o s p it a liz e d , a s lo n g a s t he y m a inta in t he r e q u ir e d d e x t e r it y , v is io n, a nd c o g n it iv e c a p a c it y t o s a f e ly im p le m e n t s uc h t e c hno lo g y [1 7 ]. A n y c o n c e r n in g g ly c e m ic d a t a s h o u ld b e s h a r e d w it h t h e h e a lt h c a r e t e a m f o r b o t h c o nf ir m a t io n a nd p o t e ntia l in t e r v e n t io n . M o s t h o s p it a ls , h o w e v e r, ha v e p o lic ie s t ha t f o r b id use o f a p a t ie nt 's p e r s o na l C G M d a t a a s t h e s o le t o o l f o r g lu c o s e m o n it o r ing o r t o g u id e g lu c o s e m a na g e m e nt s t r a t e g ie s , s u c h a s in s u lin a d m in is t r a t io n. I n s u l i n d e l i v e r y B a s a l - b o l u s (o r b a s a l - n u t r i t i o n a l ) i n s u l i n r e g i m e n s  — A lt h o u g h m o s t p a t ie n t s w ill h a v e t y p e 2 d ia b e t e s , m a n y w ill r e q u ir e a t le a s t t e m p o r a r y insulin t he r a p y d u r ing inp a t ie nt a d m is s io ns. I n s u c h p a t ie n t s , in s u lin m a y b e g iv e n s ub c u t a ne o usly w it h a n inte r m e d ia t e - a c t ing insulin, s uc h a s n e u t r a l p r o t a m in e h a g e d o r n (h u m a n N P H ), o r a lo ng - a c t ing (b a s a l) insulin a na lo g , s uc h a s g la r g in e , d e t e m ir, o r d e g lu d e c c o m b ine d w it h a p r e - m e a l r a p id - a c t ing insulin a na lo g (lis p r o , a s p a r t , g lu lis in e ) in p a t ie n t s w h o a r e e a t ing r e g u la r m e a ls (ie , a s o - c a lle d \" b a s a l- b o lus\" r e g im e n) ( a lg o r it h m 1 a n d a lg o r it h m 2 ). S h o r t - a c t in g (h u m a n r e g u la r ) h a s f a lle n o ut o f f a v o r f o r m e a l- t im e d o s in g in t h e h o s p it a l, a lt ho ug h t he r e a r e no g o o d s t ud ie s c o m p a r ing it s e f f ic a c y o r s a f e t y t o t h e m o r e c o s t ly r a p id a c t ing a na lo g s . S l i d i n g - s c a l e i n s u l i n  — W e d o n o t e n d o r s e t h e r o u t in e u s e o f r e g u la r in s u lin \"s lid in g s c a le s ,\" p a r t ic u la r ly w h e n p r o lo n g e d o v e r t he c o ur s e o f a ho s p it a liz a t io n. I t ha s no r o le w he n use d a lo ne in t h o s e w it h t y p e 1 d ia b e t e s , w h o a lw a y s r e q u ir e b a s a l insulin, e v e n w he n r e c e iv ing no t hing b y m o u t h . I n t y p e 2 d ia b e t e s p a t ie n t s w ho a r e v e r y insulin d e f ic ie nt (t y p ic a lly insulin- t r e a t e d o ld e r in d iv id u a ls , o f t e n b u t n o t a lw a y s le a n, w it h lo ng s t a nd in g d is e a s e a nd a his t o r y o f la b ile g lu c o s e s ), t h e s a m e r e c o m m e n d a t io n s a p p ly . H o w e v e r, in t h e u s u a l p a t ie n t w it h t y p e 2 d ia b e t e s m a na g e d w it h o r a l a g e nts o r inje c t a b le g lu c a g o n - lik e p e p t id e 1 (G L P - 1 )- b a s e d t he r a p ie s , a nd w ho s e g lu c o s e m a na g e m e nt o n a d m is s io n a p p e a r s a t g o a l, t h e t e m p o r a r y use o f a s lid in g s c a le is r e a s o na b le f o r just o ne t o t w o d a y s a s t h e t r a je c t o r y o f t h e p a t ie n t 's g ly c e m ia b e c o m e s a p p a r e nt (s e e 'C o r r e c t io n in s u lin ' b e lo w ). H o w e v e r, a f t e r t h is p e r io d o f t im e , a d e c is io n s ho uld b e m a d e a b o ut t he ne e d f o r a m o r e p h y s io lo g ic a l g lu c o s e m a n a g e m e n t s t r a t e g y f o r t he r e m a ind e r o f t he ho s p it a liz a t io n ( a lg o r it h m 1 a n d a lg o r it h m 2 ). T h e w id e s p r e a d u s e o f s lid in g s c a le s f o r insulin a d m inis t r a t io n f o r ho s p it a liz e d p a t ie nts b e g a n d u r in g t h e e r a o f u r in e g lu c o s e t e s t ing , a nd it inc r e a s e d a f t e r t he intr o d uc t io n o f r a p id c a p illa r y b lo o d g lu c o s e t e s t in g in t h e la s t t w o t o t hr e e d e c a d e s . H o w e v e r, t he r e a r e f e w d a t a t o s up p o r t it s b e n e f it a n d s o m e e v id e n c e o f p o t e ntia l ha r m w he n s uc h t r e a t m e n t is a p p lie d in a r o t e f a s h io n , t h a t is , w h e n a ll p a t ie n t s r e c e iv e t he s a m e o r d e r s a nd , im p o r t a ntly , w he n t he s o le f o r m o f in s u lin a d m in is t e r e d is r a p id - a c t ing insulin e v e r y f o u r t o s ix ho ur s w it ho ut und e r ly ing p r o v is io n o f b a s a l in s u lin . T h is w a s illu s t r a t e d in a n o b s e r v a t io na l s t ud y o f 1 7 1 p a t ie nts w it h d ia b e t e s w ho w e r e a d m it t e d t o a u n iv e r s it y h o s p it a l, 1 3 0 o f w h o m (7 6 p e r c e nt) w e r e p la c e d o n a s lid ing - s c a le insulin r e g im e n [1 8 ]. S lid in g - s c a le in s u lin r e g im e n s w he n a d m inis t e r e d a lo ne w e r e a s s o c ia t e d w it h a t hr e e f o ld h ig h e r r is k o f h y p e r g ly c e m ic e p is o d e s a s c o m p a r e d w it h no t he r a p y (r e la t iv e r is k [R R ] 2 .8 5 f o r \"a g g r e s s iv e \" s c a le s , b e g in n in g a t b lo o d g lu c o s e 1 5 0 m g / d L [8 .3 m m o l/ L ] a nd 3 .2 5 f o r \"c o n s e r v a t iv e \" s c a le s , b e g in n in g a t b lo o d g lu c o s e 2 0 0 m g / d L [1 1 .1 m m o l/ L ; p < 0 .0 5 ]). T hus, in t h is o b s e r v a t io n a l s t u d y , t h e u s e o f s lid in g - s c a le insulin a lo ne p r o v id e d no b e ne f it . C o r r e c t i o n i n s u l i n  — V a r y in g d o s e s o f r a p id - a c t in g in s u lin c a n b e a d d e d t o usua l p r e - m e a l r a p id - a c t in g in s u lin in p a t ie n t s o n b a s a l- b o lu s r e g im e ns t o c o r r e c t p r e - m e a l g luc o s e e x c ur s io ns. I n t h is s e t t in g , t h e a d d it io n a l in s u lin is r e f e r r e d t o a s \"c o r r e c t io n insulin \" ( a lg o r it h m 1 a n d a lg o r it h m 2 ), w h ic h d if f e r s f r o m a s lid in g s c a le b e c a use it is a d d e d t o p la n n e d m e a lt im e d o s e s t o c o r r e c t f o r p r e - m e a l h y p e r g ly c e m ia . C o r r e c t io n d o s ing t y p ic a lly s t a r t s w he n t he p r e - m e a l b lo o d g lu c o s e is ≥1 5 0 m g / d L (8 .3 m m o l/ L ). T he d o s e o f c o r r e c t io n insulin s ho uld b e in d iv id u a liz e d b a s e d u p o n r e le v a n t p a t ie nt c ha r a c t e r is t ic s , s uc h a s p r e v io us g ly c e m ia , p r e v io us in s u lin r e q u ir e m e n t s , a n d , if p o s s ib le , t he c a r b o h y d r a t e c o nte nt o f m e a ls . W he n a d m inis t e r e d p r io r t o m e a ls , t h e t y p e o f c o r r e c t io n insulin (e g , s ho r t a c t ing o r r a p id a c t ing ) s ho uld b e t he s a m e a s t h e u s u a l p r e - m e a l in s u lin . M e a l- t im e c o r r e c t io n in s u lin a lo n e is s o m e t im e s use d in p la c e o f a f ix e d m e a lt im e d o s e , usua lly w h e n r is k o f h y p o g ly c e m ia is h ig h , d ie t a r y inta k e is unc e r t a in, o r o t he r c linic a l c ir c um s t a nc e t ha t w a r r a n t s a c o n s e r v a t iv e a p p r o a c h t o g ly c e m ic m a na g e m e nt. C o r r e c t io n insulin a lo ne m a y a ls o b e u s e d a s in it ia l in s u lin t h e r a p y o r a s a d o s e - f in d in g s t r a t e g y in hy p e r g ly c e m ic p a t ie nts w it h t y p e 2 d ia b e t e s p r e v io u s ly t r e a t e d a t ho m e w it h d ie t o r no n- insulin a g e nts w ho w ill no t b e e a t in g r e g u la r ly d u r in g t h e h o s p it a liz a t io n. T his use o f c o r r e c t io n insulin is e s s e ntia lly a \"s lid ing s c a le .\" I n f a s t in g p a t ie n t s , a s h o r t - a c t ing (ie , r e g u la r ) insulin is t y p ic a lly a d m inis t e r e d e v e r y s ix h o u r s ( a lg o r it h m 2 ). R a p id - a c t in g in s u lin a n a lo g s c a n a ls o b e use d b u t m a y r e q u ir e m o r e f r e q u e n t d o s in g (u p t o e v e r y f o u r h o ur s ) a nd d o no t ha v e c le a r a d v a nta g e o v e r r e g u la r in s u lin in f a s t in g p a t ie n t s . S h o r t - a c t in g in s u lin c a n b e g iv e n a t b e d t im e in m o r e m o d e s t d o s e s t o c o r r e c t m a r k e d h y p e r g ly c e m ia (> 2 5 0 t o 3 0 0 m g / d L [1 6 .6 m m o l/ L ]). H o w e v e r, if t he p a t ie nt is e a t ing a nd f in g e r s t ic k g lu c o s e v a lu e s a r e c o n s is t e ntly e le v a t e d (> 1 8 0 m g / d L [1 0 .0 m m o l/ L ]), a c o m b ina t io n o f in t e r m e d ia t e - o r lo n g - a c t in g in s ulin a nd p r e - m e a l r a p id - a c t ing insulin (ie , a b a s a l- b o lus r e g im e n ) s h o u ld b e in it ia t e d ( a lg o r it h m 1 ). I n s u l i n i n f u s i o n  — M o s t p a t ie n t s w it h t y p e 1 o r t y p e 2 d ia b e t e s a d m it t e d t o t he g e n e r a l m e d ic a l w a r d s c a n b e t r e a t e d w it h s ub c u t a ne o us insulin. H o w e v e r, s o m e p r a c t it io ne r s instit ute in t r a v e n o u s in s u lin t h e r a p y (h u m a n r e g u la r in s u lin in s o lu t io n ) in c e r t a in c ir c u m s t a n c e s , s uc h a s t h o s e w it h m a r k e d h y p e r g ly c e m ia (b lo o d g lu c o s e > 3 0 0 t o 3 5 0 m g / d L [> 1 6 .7 t o 1 9 .4 m m o l/ L ]) o r in t y p e 1 d ia b e t e s , e s p e c ia lly t h o s e und e r g o in g lo ng a nd d if f ic u lt s ur g e r y o r t ho s e w ho w ill b e e x p e c t e d t o h a v e s ig n if ic a n t ly c u r t a ile d o r a l nutr it io na l inta k e f o r s e v e r a l d a y s p o s t o p e r a t iv e ly . T h e r e a r e lit t le d a t a s h o w in g t h a t in t r a v e no us insulin is s up e r io r t o s ub c uta ne o us insulin. T he k e y p o in t is t h a t t h e p a t ie n t s h o u ld ha v e a t le a s t a s m a ll a m o u nt o f insulin c ir c ula t ing a t a ll t im e s , w h ic h w ill s ig n if ic a n t ly in c r e a s e t he lik e liho o d o f s uc c e s s f u lly m a na g ing b lo o d g luc o s e le v e ls d u r in g illn e s s . I n a d d it io n , t h e s a f e im p le m e n t a t io n o f insulin inf u s io n p r o t o c o ls r e q uir e s f r e q ue nt m o nit o r ing o f b lo o d g lu c o s e , w h ic h is n o t t y p ic a lly a v a ila b le o n a g e n e r a l m e d ic a l w a r d . P r a c t ic a l c o n s id e r a t io n s in c lu d in g s k ill a n d a v a ila b ilit y o f t he nur s ing s t a f f m a y im p a c t t he c ho ic e o f d e liv e r y ; c o m p le x in t r a v e n o u s r e g im e n s m a y b e d a ng e r o us w he r e nur s e s a r e s ho r t s t a f f e d o r in e x p e r ie n c e d . T h u s , in s u lin in f u s io n s a r e t y p ic a lly use d in c r it ic a lly ill inte nsiv e c a r e unit (I C U ) p a t ie n t s , r a t h e r t h a n in p a t ie n t s o n t he g e n e r a l m e d ic a l w a r d s o f t he ho s p it a l. T h e r e is a la c k o f c o n s e n s u s o n h o w t o b e s t d e liv e r intr a v e no us insulin inf usio ns, a nd ind iv id ua l p a t ie n t s m a y r e q u ir e d if f e r e n t s t r a t e g ie s . T he b e s t p r o t o c o ls t a k e into a c c o unt no t o nly t he p r e v a ilin g b lo o d g lu c o s e , b u t a ls o it s r a t e o f c ha ng e a nd t he c ur r e nt insulin inf usio n r a t e . S e v e r a l p u b lis h e d in s u lin in f u s io n p r o t o c o ls a p p e a r t o b e b o t h s a f e a nd e f f e c t iv e , w it h lo w r a t e s o f h y p o g ly c e m ia , a lt h o u g h m o s t h a v e b e e n v a lid a t e d o nly in t he I C U s e t t ing , w he r e t he nur s e - t o - p a t ie n t r a t io is h ig h e r t h a n o n t h e g e n e r a l m e d ic a l a nd s ur g ic a l w a r d s [1 3 ,1 9 ,2 0 ]. T h e r e a r e f e w p u b lis h e d r e p o r t s o n s u c h p r o t o c o ls o utsid e o f t he c r it ic a l c a r e s e t t ing . C o m p ute r iz e d a nd w e b - b a s e d v e r s io n s o f s e v e r a l p r o t o c o ls a r e in w id e s p r e a d use , b u t t he y usua lly inc ur a d d it io na l c o s t s w h e n p r o p r ie t a r y d e v ic e s / s o f t w a r e a r e im p le m e n t e d [2 1 ,2 2 ]. (S e e \" G ly c e m ic c o n t r o l in c r it ic a lly ill a d u lt a n d p e d ia t r ic p a t ie nts\" .) I n t h e c o u r s e o f g iv in g a n in t r a v e n o us r e g u la r in s u lin in f u s io n , w e r e c o m m e n d s t a r t in g w it h a p p r o x im a t e ly h a lf t h e p a t ie n t 's u s u a l t o t a l d a ily insulin d o s e , d iv id e d into ho ur ly inc r e m e nts u n t il t h e t r e n d o f b lo o d g lu c o s e v a lue s is k no w n, a nd t he n a d ju s t ing t he d o s e a c c o r d ing ly . A r e a s o n a b le r e g im e n u s u a lly in v o lv e s a c o ntinuo us insulin inf u s io n a t a r a t e o f 1 t o 5 unit s o f r e g u la r in s u lin p e r h o u r ; w it h in t h is r a ng e , t he d o s e o f insulin is inc r e a s e d o r d e c r e a s e d b a s e d o n f r e q u e n t ly m e a s u r e d g lu c o s e c o nc e ntr a t io ns, id e a lly t hr o ug h t he use o f a n a p p r o v e d p r o t o c o l. I n p a t ie n t s w h o a r e n o t e a t ing , c o nc o m it a nt g lu c o s e inf u s io n is ne c e s s a r y t o p r o v id e s o m e c a lo r ie s , r e d u c e p r o t e in lo s s , a nd d e c r e a s e t he r is k o f hy p o g ly c e m ia ; s e p a r a t e inf usio ns a llo w f o r m o r e f le x ib le m a n a g e m e nt. W h e n t h e p a t ie n t r e c e iv in g in t r a v e no us insulin is m o r e s t a b le a nd t he inte r c ur r e nt e v e nt ha s p a s s e d , t h e p r io r in s u lin r e g im e n c a n b e r e s um e d , a s s um in g t ha t it w a s e f f e c t iv e in a c hie v ing g ly c e m ic g o a ls . B e c a u s e o f t h e s h o r t ha lf - lif e o f intr a v e no us r e g u la r in s u lin , t h e f ir s t d o s e o f s u b c u t a n e o u s in s u lin m u s t b e g iv e n b e f o r e d is c o ntinua t io n o f t he intr a v e no us insulin inf usio n. I f in t e r m e d ia t e - o r lo n g - a c t in g in s u lin is use d , it s ho uld b e g iv e n t w o t o t hr e e ho ur s p r io r t o d is c o n t in u a t io n , w h e r e a s s h o r t - o r r a p id - a c t ing insulin s ho uld b e g iv e n o ne t o t w o ho ur s p r io r t o s t o p p in g t h e in f u s io n . P a t i e n t s w i t h t y p e 2 d i a b e t e s  — T h e t r e a t m e n t o f p a t ie n t s w it h t y p e 2 d ia b e t e s d e p e nd s up o n p r e v io u s t h e r a p y a n d t h e p r e v a ilin g b lo o d g lu c o s e c o nc e ntr a t io ns. A ny p a t ie nt w ho t a k e s insulin b e f o r e h o s p it a liz a t io n s h o u ld r e c e iv e insulin t hr o ug h o ut t he a d m is s io n ( a lg o r it h m 1 a n d a lg o r it h m 2 ) [1 3 ]. F o r a p a t ie n t w it h r e a s o n a b le g ly c e m ic m a na g e m e nt (A 1 C ≤8 p e r c e nt) a t ho m e w it h d ie t o r a n n o n - in s u lin a g e n t (s ), in it ia l c o r r e c t io n insulin a lo ne w it h m e a ls (v a r y ing d o s e s o f r a p id - a c t ing in s u lin ) is a r e a s o n a b le in it ia l t r e a t m e n t s t r a t e g y (s e e 'C o r r e c t io n in s u lin ' a b o v e ). I f t h e p a t ie n t is u n a b le t o e a t n o r m a lly , o r a l a g e n t s (o r inje c t a b le G L P - 1 - b a s e d t he r a p ie s ) s ho uld b e d is c o n t in u e d . I n p a t ie n t s w h o a r e e a t ing a nd w ho d o no t ha v e c o ntr a ind ic a t io ns t o t he ir o r a l a g e n t , o r a l a g e n t s (o r in je c t a b le G L P - 1 - b a s e d t he r a p ie s ) m a y b e c a utio usly c o ntinue d if t he y a r e o n t h e h o s p it a l's f o r m u la r y (s e e 'P a t ie n t s t r e a t e d w it h o r a l a g e n t s o r inje c t a b le G L P - 1 - b a s e d t h e r a p ie s ' b e lo w ). H o w e v e r, if c o n t r a in d ic a t io ns d e v e lo p o r if b lo o d g lu c o s e s a r e p e r s is t e ntly e le v a t e d (> 1 8 0 m g / d L [1 0 .0 m m o l/ L ]), t he s e d r ug s s ho uld b e d is c o ntinue d a nd a m o r e f o r m a l a n d c o m p r e h e n s iv e in s u lin r e g im e n p r e s c r ib e d ( a lg o r it h m 1 a n d a lg o r it h m 2 ). T h e r a p y s h o u ld b e r e t u r n e d t o t h e p a t ie n t 's p r e v io us r e g im e n (a s s um in g t ha t it ha d b e e n e f f e c t iv e ) a s s o o n a s p o s s ib le a f t e r t h e a c u t e e p is o d e , usua lly a s s o o n a s t he p a t ie nt ha s r e s um e d e a t ing his o r h e r u s u a l d ie t . I n t h o s e w it h e le v a t e d A 1 C up o n a d m is s io n, t he d is c ha r g e r e g im e n s ho uld b e m o d if ie d t o im p r o v e g ly c e m ic m a n a g e m e nt, o r a t t he v e r y le a s t , t he p a t ie nt s ho uld b e e v a lu a t e d b y t h e c lin ic ia n m a n a g in g his o r he r d ia b e t e s s o o n (w it hin s e v e r a l w e e k s ) a f t e r d is c h a r g e . D i e t - t r e a t e d p a t i e n t s  — P a t ie n t s w it h t y p e 2 d ia b e t e s t r e a t e d b y d ie t a lo ne w ho a r e t o ha v e m in o r s u r g e r y o r a n im a g in g p r o c e d ur e , o r w ho ha v e a no nc r it ic a l a c ute illne s s t ha t is e x p e c t e d t o b e s h o r t liv e d , w ill t y p ic a lly n e e d no s p e c if ic a ntihy p e r g ly c e m ic t he r a p y . N e v e r t he le s s , r e g ula r b lo o d g lu c o s e m o n it o r in g is w a r r a nte d t o id e n t if y s e r io us hy p e r g ly c e m ia , e s p e c ia lly if s t e r o id t h e r a p y is a d m in is t e r e d . T h e m e a s ur e m e n t s y s t e m use d s ho uld b e s t a nd a r d iz e d t o e nsur e r e a s o n a b le a c c u r a c y a n d p r e c is io n . (S e e 'B lo o d g lu c o s e m o n it o r in g ' a b o v e .) I n s u lin t h e r a p y s h o u ld b e in s t it u t e d if t he p r e p r a nd ia l b lo o d g lu c o s e c o nc e ntr a t io n is p e r s is t e n t ly ≥1 8 0 m g / d L (1 0 m m o l/ L ), b u t t he p a t ie nt s ho uld b e inf o r m e d t ha t insulin m a y no t b e n e c e s s a r y a f t e r t h e e p is o d e is o v e r [1 0 ]. I n p a t ie n t s w h o a r e n o t e a t in g , c o r r e c t io n insulin (a s r e g u la r hum a n insulin) c a n b e a d m in is t e r e d e v e r y s ix h o u r s a s a c o r r e c t io n/ s lid in g s c a le ( a lg o r it h m 2 ) (s e e 'C o r r e c t io n in s u lin ' a b o v e ). C o r r e c t io n in s u lin w it h r a p id - a c t ing a na lo g s c a n a ls o b e use d , b ut t he d o s ing f r e q u e n c y m a y n e e d t o b e e v e r y f o u r ho ur s , s o t he m o r e c o s t - e f f e c t iv e r e g u la r in s u lin is p r e f e r r e d . I f s u b s t a n t ia l d o s e s a r e r e q u ir e d , a d d ing b a s a l insulin w ill im p r o v e g ly c e m ia a nd a llo w r e d u c e d t h e d o s e s o f r e g u la r insulin. I f t h e p a t ie n t is e a t in g a n d f in g e r s t ic k g lu c o s e le v e ls a r e c o nsis t e ntly e le v a t e d (≥1 8 0 m g / d L [1 0 .0 m m o l/ L ]), a b a s a l- b o lu s in s u lin r e g im e n s ho uld b e init ia t e d . I nsulin r e q uir e m e nts c a n b e e s t im a t e d b a s e d u p o n a p a t ie n t 's b o d y w e ig h t ( a lg o r it h m 1 ). A lt e r n a t iv e ly , r e q u ir e m e n t s c a n b e b a s e d u p o n t h e t o t a l n u m b e r o f unit s o f c o r r e c t io n insulin a d m inis t e r e d o v e r t he c o ur s e o f a h o s p it a l d a y . A p p r o x im a t e ly 5 0 p e r c e n t o f t he t o t a l d a ily d o s e c a n b e g iv e n a s b a s a l insulin, a nd t h e r e m a in in g a p p r o x im a t e ly 5 0 p e r c e nt c a n b e g iv e n in e q u a lly d iv id e d d o s e s p r io r t o m e a ls (o n e - t h ir d p r io r t o e a c h m e a l). P a t i e n t s t r e a t e d w i t h o r a l a g e n ts o r i n j e c t a b l e G L P - 1 - b a s e d t h e r a p i e s  — I n g e n e r a l, in s u lin is t h e p r e f e r r e d t r e a t m e n t f o r h y p e r g ly c e m ia in ho s p it a liz e d p a t ie nts p r e v io usly t r e a t e d w it h o r a l a g e n t s (o r in je c t a b le g lu c a g o n- lik e p e p t id e 1 [G L P - 1 ]- b a s e d t he r a p ie s ). T his a p p r o a c h s t e m s f r o m t h e f a c t t h a t in s u lin d o s e s c a n b e r a p id ly a d ju s t e d a nd , t he r e f o r e , c a n q uic k ly c o r r e c t w o r s e n in g h y p e r g ly c e m ia . I n a d d it io n , no ninsulin d ia b e t e s t he r a p ie s ha v e no t b e e n w id e ly t e s t e d in t h e h o s p it a l s e t t in g . H o w e v e r, t he r e a r e s o m e c ir c um s t a nc e s w he r e insulin m a y no t b e n e c e s s a r y . A s a n e x a m p le , in p a t ie nts w ho a r e w e ll m a na g e d o n t he ir o utp a t ie nt r e g im e n, w ho a r e e a t in g , a n d in w h o m n o c h a n g e in t he ir m e d ic a l c o nd it io n o r nutr it io na l inta k e is a n t ic ip a t e d , o r a l a g e n t s m a y b e c o ntinue d , a s lo ng a s ne w c o ntr a ind ic a t io ns a r e ne it he r p r e s e nt n o r a n t ic ip a t e d d u r in g t h e h o s p it a l a d m is s io n, a nd a s lo ng a s t he m e d ic a t io ns (o r s im ila r b r a n d s ) a r e o n t h e h o s p it a l f o r m u la r y . O f no t e , inje c t a b le G L P - 1 - b a s e d t he r a p ie s a r e e x p e nsiv e a n d o f t e n n o t o n h o s p it a l f o r m u la r ie s ; t he ir use in t he ho s p it a l s e t t ing is t he r e f o r e unc o m m o n. I f a p a t ie n t w a s p r e v io u s ly e a t in g b ut is una b le t o e a t a f t e r t he e v e ning m e a l in p r e p a r a t io n f o r a p r o c e d u r e t h e n e x t m o r n in g , o r a l a n t ihy p e r g ly c e m ic d r ug s s ho uld b e o m it t e d o n t he d a y o f a p r o c e d u r e (s u r g ic a l o r d ia g n o s t ic ). I f p r o c e d u r e s a r e a r r a ng e d a s e a r ly in t he d a y a s p o s s ib le , a n t ih y p e r g ly c e m ic t h e r a p y a n d f o o d inta k e c a n s im p ly t he n b e s hif t e d t o la t e r in t he d a y . I f t h e illn e s s r e q u ir in g a d m is s io n is m o r e s e v e r e (e g , a n inf e c t io n r e q uir ing ho s p it a liz a t io n), h y p e r g ly c e m ia is m o r e lik e ly , e v e n w he n t he r e is d e c r e a s e d f o o d inta k e , a nd m o s t a c ute ly ill p a t ie n t s w ill n e e d in s u lin . I n t h is s e t t ing , o r a l a g e n t s s ho uld b e d is c o ntinue d . O v e r t h y p e r g ly c e m ia (≥1 8 0 m g / d L [1 0 .0 m m o l/ L ]) in p a t ie nts p r e v io usly t r e a t e d w it h o r a l a g e nts w ho a r e n o t e a t in g c a n b e t r e a t e d b r ie f ly w it h inte r m it t e nt, s ub c u t a ne o us d o s e s o f r e g ula r (e v e r y s ix h o u r s ) o r r a p id - a c t in g (e v e r y f o u r t o s ix ho ur s ) insulin, p r o v id e d t he b lo o d g luc o s e is no t s e v e r e ly e le v a t e d , r e s p o n d s w e ll t o t he insulin, a nd t he p r o b le m la s t s o nly a d a y o r t w o a t m o s t (s e e 'C o r r e c t io n in s u lin ' a b o v e ). I f e a t in g , r a p id - a c t in g in s ulin is p r e f e r r e d , a d m inis t e r e d b e f o r e m e a ls . H o w e v e r, a m o r e f o r m a l a n d c o m p r e he nsiv e insulin r e g im e n, inc lud ing s o m e f o r m o f b a s a l in s u lin , is u s u a lly p r e f e r r e d w he n hy p e r g ly c e m ia p e r s is t s ( a lg o r it h m 1 a n d a lg o r it h m 2 ). O r a l a g e n t s s h o u ld g e n e r a lly n o t b e a d m inis t e r e d t o p a t ie nts w ho a r e no t e a t ing . I n a d d it io n, m a n y o r a l a g e n t s h a v e s p e c if ic c o n t r a ind ic a t io ns t ha t m a y e m e r g e in ho s p it a liz e d p a t ie nts: M e t f o r m in – M e t f o r m in is c o n t r a in d ic a t e d in s it ua t io ns in w hic h k id n e y f u nc t io n a nd / o r h e m o d y n a m ic s t a t u s is e it h e r im p a ir e d o r t hr e a t e ne d , d u e t o t he inc r e a s e d r is k o f la c t ic a c id o s is . E x a m p le s in c lu d e p a t ie n t s w it h a c ute c a r d ia c o r p u lm o n a r y d e c o m p e nsa t io n, a c u t e k id n e y in ju r y , d e h y d r a t io n , s e p s is , ur ina r y o b s t r uc t io n, o r in t ho s e und e r g o ing s u r g e r y o r r a d io c o n t r a s t s t u d ie s . G iv e n t he t y p ic a l c a s e m ix in m o s t a c ute c a r e ho s p it a ls , m e t f o r m in s h o u ld p r o b a b ly b e d is c o n t inue d a t le a s t t e m p o r a r ily in m o s t p a t ie nts. (S e e \" M e t f o r m in in t h e t r e a t m e n t o f a d u lt s w it h t y p e 2 d ia b e t e s m e llit us\" , s e c t io n o n 'C o n t r a in d ic a t io n s '.) ● D P P - 4 i n h i b i t o r s – D ip e p t id y l p e p t id a s e 4 (D P P - 4 ) in hib it o r s (e g , s it a g lip t in , s a x a g lip t in , lin a g lip t in , a lo g lip t in ) e x e r t t h e ir e f f e c t m a in ly in t h e p o s t p r a nd ia l s e t t ing . A s a r e s ult , t he y h a v e a n u n c e r t a in r o le in p a t ie n t s w ho a r e no t e a t ing . D P P - 4 inhib it o r s ha v e no t b e e n use d o r s t u d ie d e x t e n s iv e ly in t h e a c u t e c a r e s e t t ing [2 3 ]. T w o s t u d ie s s u g g e s t e d t h a t t h e y m a y b e r e a s o n a b ly e f f e c t iv e in m ild ly h y p e r g ly c e m ic p a t ie nts w it h t y p e 2 d ia b e t e s w ho a r e e a t in g [2 3 ,2 4 ]. W e t e n d t o c o n t in u e t h e m a s t h e y m a y m o d e s t ly r e d u c e hy p e r g ly c e m ia a nd d e c r e a s e t h e n e e d f o r in s u lin in je c t io ns. T he y a ls o ha v e f e w c o ntr a ind ic a t io ns o r s a f e t y c o n c e r n s , a n d D P P - 4 in h ib it o r s d o no t inc r e a s e t he r is k o f hy p o g ly c e m ia . A ll D P P - 4 in h ib it o r s e x c e p t lin a g lip t in r e q u ir e d o s e r e d u c t io n in t he s e t t ing o f im p a ir e d k id ne y f u n c t io n . (S e e \" D ip e p t id y l p e p t id a s e 4 (D P P - 4 ) in h ib it o r s f o r t he t r e a t m e n t o f t y p e 2 d ia b e t e s m e llit u s \" , s e c t io n o n 'D o s ing '.) ● S u l f o n y l u r e a s – S u lf o n y lu r e a s (e g , g ly b u r id e , g lip iz id e , g lim e p ir id e ) a r e a s s o c ia t e d w it h h y p o g ly c e m ia t h a t c a n b e s e v e r e a n d p r o lo ng e d . A lt ho ug h t he y m a y b e c o ntinue d d ur ing t h e h o s p it a liz a t io n in s t a b le p a t ie n t s w ho a r e e x p e c t e d t o e a t r e g u la r ly , une x p e c t e d a lt e r a t io n s in m e a l in t a k e w ill in c r e a s e t he r is k f o r hy p o g ly c e m ia . ● O n b a la n c e , s u lf o n y lu r e a s s h o u ld u s ua lly b e d is c o ntinue d , a t le a s t t e m p o r a r ily , in t he h o s p it a liz e d p a t ie n t . (S e e \" S u lf o n y lu r e a s a n d m e g lit in id e s in t he t r e a t m e n t o f t y p e 2 d ia b e t e s m e llit u s \" , s e c t io n o n 'C a r d io v a s c ula r e f f e c t s '.) M e g l i t i n i d e s – N o n - s u lf o n y lu r e a s e c r e t a g o g u e s (m e g lit inid e s [e g , r e p a g lin id e , n a t e g lin id e ]) w o r k s im ila r ly t o t h e s u lf o n y lu r e a s b u t ha v e a s ho r t e r d u r a t io n o f a c t io n. A s a r e s u lt , t h e s e p r a n d ia l- a d m in is t e r e d d r ug s m a y ha v e a t he o r e t ic a l a d v a nta g e in h o s p it a liz e d p a t ie n t s b u t s h o u ld a ls o b e use d c a utio usly , inc lud in g in t ho s e w it h a c ute is c h e m ic h e a r t d is e a s e e v e n t s . F u r t he r lim it ing t he ir inp a t ie nt use , m e g lit inid e s a r e ● t y p ic a lly n o t o n h o s p it a l f o r m u la r ie s . (S e e \" S u lf o n y lu r e a s a n d m e g lit in id e s in t he t r e a t m e n t o f t y p e 2 d ia b e t e s m e llit u s \" .) G L P - 1 - b a s e d t h e r a p i e s – G L P - 1 - b a s e d t h e r a p ie s (e g , e x e n a t id e , lir a g lu t id e , lix is e n a t id e [lim it e d a v a ila b ilit y ], d u la g lu t id e , s e m a g lu t id e , t ir z e p a t id e ) m a y r e s u lt in n a u s e a a n d d e c r e a s e d c a lo r ie in t a k e a n d a r e m o r e e f f e c t iv e f o r p o s t p r a nd ia l g lu c o s e m a na g e m e nt. A s a r e s u lt , t h e ir u s e s h o u ld g e n e r a lly b e a v o id e d in t he a c ute s e t t ing . T he y a r e a ls o no t u s u a lly in c lu d e d o n m o s t h o s p it a l f o r m u la r ie s , in p a r t d u e t o hig h c o s t . (S e e \" G lu c a g o n - lik e p e p t id e 1 - b a s e d t h e r a p ie s f o r t h e t r e a t m e n t o f t y p e 2 d ia b e t e s m e llit us\" , s e c t io n o n 'I n t r o d u c t io n '.) ● S G L T 2 i n h i b i t o r s – S o d iu m - g lu c o s e c o t r a n s p o r t e r 2 (S G L T 2 ) inhib it o r s (e g , d a p a g lif lo z in , c a n a g lif lo z in , e m p a g lif lo z in ) p r o m o t e t h e r e n a l e x c r e t io n o f g lu c o s e . T he y inc r e a s e c a lo r ie lo s s e s a s w e ll a s r is k o f d e h y d r a t io n, v o lum e c o ntr a c t io n, a nd g e n it o ur ina r y t r a c t in f e c t io n s . I n a d d it io n , e u g ly c e m ic d ia b e t ic k e t o a c id o s is ha s b e e n r e p o r t e d in p a t ie nts w it h b o t h t y p e 1 (d u r in g o f f - la b e l u s e ) a nd , m o r e r a r e ly , t y p e 2 d ia b e t e s w ho w e r e t a k ing S G L T 2 in h ib it o r s . T h e s e d r u g s s h o u ld t h e r e f o r e g e n e r a lly no t b e use d in t he inp a t ie nt s e t t ing , p a r t ic u la r ly w h e n p a t ie n t s a r e a c u t e ly ill, a lt ho ug h t he y m a y b e s t a r t e d just p r io r t o d is c h a r g e if c o m p e llin g in d ic a t io n s a r e p r e s e nt. F o r e x a m p le , t he s e a g e nts m a y b e use d b y c a r d io lo g is t s a n d e s p e c ia lly h e a r t f a ilur e s p e c ia lis t s f o r t he b e n e f it o f S G L T 2 inhib it o r s in t h e s e t t in g o f h e a r t f a ilu r e . (S e e \" S o d iu m - g lu c o s e c o t r a n s p o r t e r 2 inhib it o r s f o r t he t r e a t m e n t o f h y p e r g ly c e m ia in t y p e 2 d ia b e t e s m e llit us\" , s e c t io n o n 'A d v e r s e e f f e c t s ' a n d \" P r im a r y p h a r m a c o lo g ic t h e r a p y f o r he a r t f a ilur e w it h r e d u c e d e je c t io n f r a c t io n \" , s e c t io n o n 'S o d iu m - g lu c o s e c o - t r a n s p o r t e r 2 inhib it o r s ' a n d \" T r e a t m e n t a n d p r o g n o s is o f h e a r t f a ilu r e w it h p r e s e r v e d e je c t io n f r a c t io n \" , s e c t io n o n 'S o d iu m - g lu c o s e c o - t r a nsp o r t e r 2 in h ib it o r s '.) ● T h i a z o l i d i n e d i o n e s – T h e t h ia z o lid in e d io n e s (e g , p io g lit a z o n e , r o s ig lit a z o n e ) a r e a s s o c ia t e d w it h p e r ip h e r a l e d e m a a nd s ho uld b e a v o id e d in p a t ie nts w it h he a r t f a ilur e . I f t h e q u e s t io n o f v e n t r ic u la r d y s f u n c t io n is r a is e d d u r ing a ho s p it a liz a t io n, t h ia z o lid in e d io n e s s h o u ld b e h e ld u ntil t he s it ua t io n is c la r if ie d . T he a ntihy p e r g ly c e m ic e f f e c t o f t h is d r u g c la s s e x t e n d s f o r s e v e r a l w e e k s a f t e r d is c o ntinua t io n (a s d o e s t he f luid - r e t a in in g e f f e c t ), s o t h a t t e m p o r a r y inte r r up t io n o f t he r a p y s ho uld ha v e lit t le e f f e c t o n g ly c e m ia . (S e e \" T h ia z o lid in e d io n e s in t h e t r e a t m e nt o f t y p e 2 d ia b e t e s m e llit us\" .) ● A l p h a - g l u c o s i d a s e i n h i b i t o r s – A lp h a - g lu c o s id a s e in h ib it o r s (e g , a c a r b o s e , m ig lit o l) a r e g e n e r a lly u s e d in f r e q u e n t ly a n d a r e no t t y p ic a lly o n ho s p it a l f o r m u la r ie s . M o r e o v e r, t he s e in h ib it o r s o f in t e s t in a l c a r b o h y d r a t e a b s o r p t io n a r e o nly e f f e c t iv e in p a t ie nts w ho a r e ● P a t i e n t s t r e a t e d w i t h i n s u l i n  — I n s u lin t h e r a p y s h o u ld b e c o n t in u e d in a ll p a t ie nts a lr e a d y t a k in g it t o m a in t a in a r e a s o n a b ly c o n s t a nt b a s a l le v e l o f c ir c ula t ing insulin. F a iling t his , s e v e r e h y p e r g ly c e m ia o r e v e n k e t o a c id o s is c a n o c c ur, e v e n in p a t ie nts la b e le d a s ha v ing t y p e 2 d ia b e t e s b u t w h o h a v e b e c o m e s ig nif ic a ntly insulin d e f ic ie nt o v e r a p r o lo ng e d d is e a s e c o ur s e . e a t in g a n d t h e r e f o r e h a v e a lim it e d r o le in t his s e t t ing . (S e e \"A lp h a - g lu c o s id a s e in h ib it o r s f o r t r e a t m e n t o f d ia b e t e s m e llit u s \" .) B a s a l - b o l u s (o r b a s a l - n u t r i t i o n a l ) r e g i m e n s – I n t h e n o n - a c u t e h o s p it a l s e t t in g a nd w he n t h e p a t ie n t is e a t in g r e g u la r ly , b a s a l insulin (N P H o r d e t e m ir t w ic e d a ily o r g la r g ine , d e t e m ir, o r d e g lu d e c o n c e d a ily [o r nig h t ly ]) in c o m b ina t io n w it h s ho r t - o r r a p id - a c t ing p r a n d ia l (b o lu s ) in s u lin (r e g u la r, lis p r o , a s p a r t , g lu lis ine ) is g e n e r a lly e f f e c t iv e f o r p a t ie nts r e c e iv in g in s u lin a t h o m e o r f o r p a t ie nts w it h p o o r ly r e g u la t e d b lo o d g luc o s e p r e v io usly m a n a g e d w it h d ie t o r o r a l a g e n t s ( a lg o r it h m 1 ). ● I f t h e g lu c o s e w a s w e ll m a n a g e d w it h t he o utp a t ie nt insulin r e g im e n, w e t y p ic a lly r e d uc e t h e d o s e b y 2 5 t o 5 0 p e r c e n t b e c a u s e , in t he m o r e c o ntr o lle d e nv ir o nm e nt o f t he ho s p it a l (w h e r e t h e a m o u n t o f f o o d c o n s u m e d m a y b e le s s t ha n a t ho m e a nd b lo o d g luc o s e le v e ls a r e c h e c k e d r e g u la r ly ), p a t ie n t s m a y ne e d c o nsid e r a b ly le s s insulin t ha n t he y w e r e t a k ing in t h e o u t p a t ie n t s e t t in g . H o w e v e r, c linic ia ns s ho uld b e r e a d y t o r a p id ly a d v a nc e t he d o s e if t h is r e d u c t io n r e s u lt s in in a d e q u a t e g ly c e m ic m a na g e m e nt. D if f e r e n t b a s a l- b o lu s r e g im e n s a r e s im ila r ly e f f e c t iv e in r e d u c ing A 1 C c o nc e ntr a t io ns w he n in s u lin d o s e s a r e t it r a t e d t o a c h ie v e g ly c e m ic g o a ls . A s a n e x a m p le , in a t r ia l o f d e t e m ir / a s p a r t v e r s u s N P H / r e g u la r in 1 3 0 ho s p it a liz e d p a t ie nts, t he r e w a s no d if f e r e nc e in g ly c e m ic m a n a g e m e n t o r f r e q u e n c y o f hy p o g ly c e m ia b e t w e e n t he t w o r e g im e ns [2 5 ]. I n s o m e s t u d ie s , t r e a t m e n t w it h s u c h a b a s a l- b o lu s insulin r e g im e n w a s a s s o c ia t e d w it h b e t t e r g ly c e m ic o u t c o m e s t h a n s lid in g - s c a le insulin [2 6 - 2 9 ]. A s a n e x a m p le , in o n e o p e n - la b e l, r a n d o m iz e d t r ia l o f in s u lin g la r g in e s u p p le m e n t e d w it h p r e p r a n d ia l g lulis ine v e r s us s lid in g - s c a le in s u lin , a g r e a t e r p r o p o r t io n o f p a t ie nts t r e a t e d w it h t he b a s a l- b o lus r e g im e n a c h ie v e d t a r g e t g lu c o s e v a lu e s (6 6 v e r s us 3 8 p e r c e nt, r e s p e c t iv e ly ) [2 6 ]. H o w e v e r, in t h is s t u d y , t h e m e a n d a ily d o s e o f in s u lin w a s m o r e t ha n t hr e e f o ld hig h e r in t he b a s a l- b o lus- t r e a t e d p a t ie n t s t h a n in t h o s e a s s ig ne d t o s lid in g s c a le , lik e ly r e f le c t ing a f a ilur e t o t it r a t e t h e d o s e s o f s lid in g - s c a le in s u lin . I n s o m e [2 8 ,2 9 ], b u t n o t a ll [2 6 ,2 7 ], t r ia ls , b e t t e r g ly c e m ic m a n a g e m e n t w it h b a s a l- b o lu s v e r s u s s lid in g - s c a le insulin w a s a s s o c ia t e d w it h m o r e h y p o g ly c e m ia (g lu c o s e < 7 0 m g / d L [3 .9 m m o l/ L ] in 2 3 .1 a nd 4 .7 p e r c e nt o f p a t ie nts, r e s p e c t iv e ly , a n d < 4 0 m g / d L [2 .2 m m o l/ L ] in 3 .8 a nd 0 p e r c e nt, r e s p e c t iv e ly ). U - 5 0 0 i n s u l i n – P a t ie n t s t r e a t e d w it h U - 5 0 0 r e g u la r in s u lin a t h o m e m a y c o n t in u e U - 5 0 0 (w it h a 5 0 p e r c e n t d o s e r e d u c t io n s in c e g lu c o s e v a lue s o f t e n im p r o v e s ub s t a ntia lly in t he h o s p it a l in p a t ie n t s p r e v io u s ly r e q u ir ing la r g e d o s e s o f insulin a t ho m e , d ue t o m o r e r e s t r ic t iv e h o s p it a l d ie t s ), if it is a v a ila b le f r o m t he ho s p it a l f o r m u la r y . B e c a use t he hig h c o n c e n t r a t io n o f in s u lin d e la y s a b s o r p t io n, t he p h a r m a c o lo g ic p r o f ile o f U - 5 0 0 r e g ula r in s u lin is m o s t s im ila r t o t h a t o f N P H [3 0 ]. T h u s , if U - 5 0 0 is n o t a v a ila b le , U - 1 0 0 N P H insulin t w ic e d a ily s h o u ld b e s u b s t it u t e d (a g a in, w it h a 5 0 p e r c e nt d o s e r e d u c t io n). ● W e w o u ld a ls o c a u t io n t h a t e r r o r s a r e c o m m o n w it h U - 5 0 0 a d m inis t r a t io n, a nd c le a r c o m m u n ic a t io n a m o n g p a t ie n t , c linic ia n, nur s ing s t a f f, a nd p h a r m a c y is im p e r a t iv e t o e n s u r e p r o p e r d o s in g . A lt h o u g h in t he p a s t U - 5 0 0 insulin w a s d is p e n s e d using s t a nd a r d U - 1 0 0 in s u lin o r T u b e r c u lin s y r in g e s , a d e d ic a t e d U - 5 0 0 insulin s y r ing e is a v a ila b le a nd U - 5 0 0 in s u lin s h o u ld b e d is p e n s e d w it h t h e U - 5 0 0 insulin s y r ing e , if p o s s ib le [3 1 ]. T h e s y r in g e c o n t a in s s c a le m a r k in g s f r o m 2 5 t o 2 5 0 unit s in 5 - unit inc r e m e n t s (t o t a l v o lum e 0 .5 m L ). T h e in s u lin d o s e s h o u ld b e e x p r e s s e d in unit s , r a t he r t ha n in v o lum e t r ic t e r m s a s w a s t he c o n v e n t io n w it h t h e T u b e r c u lin o r U - 1 0 0 s y r ing e s . U - 5 0 0 insulin s y r ing e s a r e no t a v a ila b le w it h a s a f e t y n e e d le a n d , t h e r e f o r e , m a y no t b e a llo w e d in s o m e f a c ilit ie s . I n s uc h c a s e s , t h e U - 5 0 0 in s u lin p e n d e v ic e m a y b e use d . T he p e n d o s ing w ind o w s ho w s t he num b e r o f u n it s o f U - 5 0 0 t o b e in je c t e d , a n d t he p e n d e liv e r s t he v o lum e t ha t c o r r e s p o nd s t o t he s e le c t e d d o s e . T h e p e n c o n t a in s 1 5 0 0 unit s (5 0 0 unit s / m L ) o f insulin. I f n e it h e r d e d ic a t e d U - 5 0 0 in s u lin s y r ing e s no r t he U - 5 0 0 insulin p e n d e v ic e is a v a ila b le , U - 5 0 0 in s u lin c a n b e d is p e n s e d u s in g a T ub e r c ulin s y r ing e , r a t he r t ha n a U - 1 0 0 insulin s y r in g e , t o e m p h a s iz e t h a t it is d if f e r e nt f r o m U - 1 0 0 r e g u la r in s u lin . W it h t h e T u b e r c u lin s y r in g e , e v e r y 0 .1 m L w o u ld e q u a l 5 0 unit s o f insulin. T he o b v io u s c o nc e r n w he n using U - 5 0 0 in s u lin w it h a T u b e r c u lin s y r in g e is t he p o t e ntia l f o r c o nf u s io n o f v o lum e a nd unit s . F o r in s t it u t io n s u s in g T u b e r c u lin s y r in g e s t o d e liv e r U - 5 0 0 insulin, t he r e f o r e , U - 5 0 0 insulin s h o u ld b e d is p e n s e d d ir e c t ly f r o m t he ho s p it a l p h a r m a c y , in ind iv id ua lly la b e lle d T u b e r c u lin s y r in g e s . I n s u l i n p u m p – I n p a t ie n t s w it h t y p e 2 d ia b e t e s a lr e a d y using a n insulin p u m p , p u m p t h e r a p y m a y b e c o n t in u e d in t h e h o s p it a l s o lo ng a s c e r t a in c r it e r ia a r e m e t f o r s a f e im p le m e n t a t io n . (S e e 'P a t ie n t s w it h t y p e 1 d ia b e t e s ' b e lo w .) ● A u t o m a t e d in s u lin d e liv e r y (A I D ) s y s t e m s a r e t y p ic a lly use d in t he o utp a t ie nt s e t t ing , m o r e o f t e n in p a t ie n t s w it h t y p e 1 d ia b e t e s . I n a s ho r t - t e r m t r ia l c o m p a r ing a n A I D s y s t e m w it h c o n v e n t io n a l s u b c u t a n e o u s in s u lin t he r a p y in ho s p it a liz e d p a t ie nts (no nc r it ic a l c a r e ) w it h t y p e 2 d ia b e t e s , a g r e a t e r p r o p o r t io n o f p a t ie nts r e c e iv ing A I D w e r e in t he t a r g e t r a ng e o f 1 0 0 t o 1 8 0 m g / d L (5 .6 t o 1 0 m m o l/ L ; 6 5 .8 v e r s us 4 1 .5 p e r c e nt) [3 2 ]. M e a n g lu c o s e le v e l w a s P a t i e n t s w i t h t y p e 1 d i a b e t e s  — P a t ie n t s w it h t y p e 1 d ia b e t e s h a v e a n a b s o lute r e q u ir e m e n t f o r in s u lin a t a l l t i m e s , w h e t h e r o r n o t t h e y a r e e a t in g , t o p r e v e nt k e t o s is . T he d o s e s o f insulin n e e d e d a r e u s u a lly lo w e r t h a n in p a t ie nts w it h t y p e 2 d ia b e t e s s inc e m o s t o f t he f o r m e r d o no t h a v e in s u lin r e s is t a n c e . H o w e v e r, t he ir b lo o d g lu c o s e c o nc e ntr a t io ns t e nd t o f luc t ua t e m o r e d u r in g t h e c o u r s e o f t h e illn e s s o r p r o c e d u r e . I t is im p o r t a nt t o a v o id hy p o g ly c e m ia , e v e n if t he c o n s e q u e n c e is a t e m p o r a r y m o d e s t r is e in t he b lo o d g lu c o s e c o nc e ntr a t io n. I n s u lin c a n b e g iv e n e it h e r s u b c u t a ne o usly o r intr a v e no usly . A lg o r it hm s f o r g ly c e m ic m a n a g e m e n t o f n o n f a s t in g a n d f a s t ing p a t ie nts w it h t y p e 1 d ia b e t e s w ho a r e no t c r it ic a lly ill a r e s h o w n f o r s u b c u t a n e o u s d o s in g r e g im e ns ( a lg o r it h m 1 a n d a lg o r it h m 2 ) [1 3 ]. I f t h e p a t ie n t is r e c e iv in g n o t h in g b y m o u t h, t he a d m inis t r a t io n o f b a s a l insulin is s t ill r e q uir e d . A s e x a m p le s : lo w e r w it h A I D (1 5 4 v e r s u s 1 8 8 m g / d L in t he c o ntr o l g r o up [8 .5 v e r s us 1 0 .4 m m o l/ L ]), b ut t h e r e w a s n o s ig n if ic a n t d if f e r e n c e in d u r a t io n o f hy p o g ly c e m ia o r in t he a m o unt o f insulin d e liv e r e d . W h e t h e r t h e m o d e s t im p r o v e m e n t in g ly c e m ia in no nc r it ic a l ho s p it a liz e d p a t ie n t s im p r o v e s o u t c o m e s a n d w a r r a nts t he p o t e ntia l inc r e a s e d c o s t is unc e r t a in. (S e e \" C o n t in u o u s s u b c u t a n e o u s in s u lin inf u s io n (insulin p u m p )\" , s e c t io n o n ' T y p e s o f insulin p u m p s '.) R e d u c e d o r a b s e n t o r a l i n t a k e – W h e n f o o d in t a k e is d im in is h e d o r s t o p p e d c o m p le t e ly in a p a t ie n t t r e a t e d w it h in s u lin (e g , in p r e p a r a t io n f o r s ur g e r y o r o t he r p r o c e d ur e s ), p la n n e d p r e - m e a l r a p id - a c t in g in s u lin is d is c o ntinue d , a nd t he d o s e o f inte r m e d ia t e - o r lo n g - a c t in g in s u lin is r e d u c e d . I f a n e p is o d e is c le a r ly s ho r t liv e d (e g , a p r o c e d ur e d o ne in t h e e a r ly m o r n in g ), s u b c u t a n e o u s in s ulin (usua l d o s e o f s ho r t a c t ing a nd inte r m e d ia t e o r lo n g a c t in g ) a n d b r e a k f a s t c a n s im p ly b e d e la y e d until a f t e r t he e p is o d e . T he a d justm e nt o f in s u lin d o s e s in p r e p a r a t io n f o r s ur g e r y o r o t he r p r o c e d u r e s is r e v ie w e d in m o r e d e t a il s e p a r a t e ly . (S e e \" P e r io p e r a t iv e m a n a g e m e n t o f b lo o d g lu c o s e in a d u lt s w it h d ia b e t e s m e llit u s \" , s e c t io n o n 'I n s u lin in je c t io n '.) ● O n c e t h e p a t ie n t is t a k in g a n o r m a l d ie t , t he usua l a t - ho m e r e g im e n c a n b e r e s t a r t e d , a s lo n g a s g ly c e m ic g o a ls w e r e b e in g m e t . I f a lt e r e d nutr it io na l inta k e is p r e s e nt, r e d uc e d d o s e s o f in s u lin w ill b e r e q u ir e d , s t a r t ing w it h d o s e s s im ila r t o t ho s e a d m inis t e r e d in t he p r e p r o c e d u r e s e t t in g . P a t i e n t s u s i n g a n i n s u l i n p u m p – F o r a p a t ie n t t r e a t e d w it h a c o n t inuo us insulin inf u s io n v ia a p u m p , t h e b a s a l in s u lin c a n b e c o ntinue d a t t he usua l r a t e , o r t he o v e r nig ht b a s a l r a t e m a y b e r e d u c e d b y 2 0 p e r c e n t t o m in im iz e t he r is k o f hy p o g ly c e m ia t he ne x t m o r ning . N o b o lu s e s w o u ld b e a d m in is t e r e d until t he p a t ie nt is a b le t o e a t . S inc e nur s ing s t a f f a r e ● P a t i e n t s r e c e i v i n g e n t e r a l o r p a r e n te r a l f e e d i n g s  — P a t ie n t s w it h d ia b e t e s w h o a r e r e c e iv ing t o t a l p a r e n t e r a l n u t r it io n (T P N ) o r t u b e f e e d s (b o lu s o r c o n t inuo us) r e q u ir e s p e c ia l c o n s id e r a t io n . T P N  — I n p a t ie n t s r e c e iv in g t o t a l p a r e n t e r a l n u t r it io n (T P N ), in s u lin m a y b e a d m in is t e r e d a s p a r t o f t h e n u t r it io n a l s o lu t io n , if a llo w e d b y t he ho s p it a l p h a r m a c y . To d e t e r m ine t he c o r r e c t n o t a lw a y s f a m ilia r o r c o m f o r t a b le w it h t he use o f insulin p u m p s , p a t ie nts s ho uld b e a le r t e n o u g h t o m a n a g e t h e ir p u m p t h e r a p y a nd p o s s e s s s uf f ic ie nt v is io n a nd d e x t e r it y t o s a f e ly u s e t h e d e v ic e . I n a d d it io n , v ig ila nc e r e g a r d in g p u m p c a t he t e r p la c e m e nt is n e c e s s a r y . C a t h e t e r s m a y in a d v e r t e n t ly b e d is lo d g e d d u r ing t r a nsf e r s in t he o p e r a t ing r o o m o r in b e d , a n d if t h e p a t ie n t is no t a le r t e no ug h t o p r o v id e s e lf - c a r e , t he he a lt h c a r e p r o v id e r s s h o u ld c o n s id e r c h a n g in g t o c o nv e ntio na l inje c t io n t he r a p y until t he p a t ie nt is a b le t o m a n a g e p u m p t h e r a p y a g a in. P a t i e n t s t r e a t e d w i t h m u l t i p l e d a i l y i n s u l i n i n j e c t i o n s – F o r a p a t ie n t w h o u s u a lly t a k e s 2 0 u n it s o f g la r g in e e v e r y e v e n in g a nd r a p id - a c t ing insulin b e f o r e e a c h m e a l (d o s e b a s e d u p o n p r e - m e a l b lo o d g lu c o s e a n d c a r b o h y d r a t e c o nte nt o f m e a l), t he usua l d o s e o f g la r g in e c a n b e c o n t in u e d . I n p a t ie nts w it h t ig h t ly m a na g e d g ly c e m ia , a n a lt e r na t iv e a p p r o a c h is t o r e d u c e t h e d o s e o f g la r g in e b y 1 0 t o 2 0 p e r c e nt (e g , g iv e 1 6 t o 1 8 unit s ) t o m in im iz e t h e r is k o f h y p o g ly c e m ia t ha t m ig ht r e q u ir e o r a l ing e s t io n o f c a lo r ie s a nd t h e r e b y d e la y t h e p la n n e d p r o c e d ur e . S ho r t - a c t ing insulin s ho uld no t b e g iv e n, unle s s s ig n if ic a n t h y p e r g ly c e m ia is n o t e d , a s d e s c r ib e d a b o v e . ● F o r a p a t ie n t w h o u s u a lly t a k e s 2 4 unit s o f N P H a nd 4 unit s o f r e g u la r in s u lin in t h e m o r n in g , o n e - h a lf t o t w o - t h ir d s (1 2 t o 1 6 unit s ) o f t he usua l m o r ning d o s e o f N P H insulin c a n b e g iv e n (if t h e m o r n in g b lo o d g lu c o s e v a lue is no t t o o lo w , ie , is a t le a s t 1 2 0 m g / d L [6 .7 m m o l/ L ]). S h o r t - o r r a p id - a c t in g insulin s ho uld no t b e g iv e n , e x c e p t if s ig nif ic a nt h y p e r g ly c e m ia (> 2 0 0 t o 2 5 0 m g / d L [1 1 .1 t o 1 3 .9 m m o l/ L ]) is f o u nd in t he m o r ning . I n s uc h c a s e s , o n ly s m a ll d o s e s (1 t o 4 u n it s ) s ho uld b e g iv e n w it h t he g o a ls o f r e d uc ing t he b lo o d g lu c o s e le v e l t o < 1 8 0 m g / d L (1 0 m m o l/ L ) a nd a v o id in g hy p o g ly c e m ia d ur ing t he o ng o ing f a s t . B lo o d g lu c o s e s h o u ld b e m e a s u r e d e v e r y t w o t o t hr e e ho ur s until t he f ir s t m e a l is e a t e n. S m a ll a m o u n t s o f s h o r t - o r r a p id - a c t ing insulin c a n b e a d m inis t e r e d e v e r y f o ur t o s ix ho ur s t o c o r r e c t h y p e r g ly c e m ia (ie , g lu c o s e > 1 5 0 t o 2 0 0 m g / d L [8 .3 t o 1 1 .1 m m o l/ L ]). I ntr a v e no us g lu c o s e (a t a p p r o x im a t e ly 3 .7 5 t o 5 g / ho ur, e g , 5 p e r c e nt d e x t r o s e a t 7 5 t o 1 0 0 m L p e r h o u r ) s h o u ld b e g iv e n t o lim it t h e m e t a b o lic c ha ng e s o f s t a r v a t io n. (S e e \" C a s e s illu s t r a t in g in t e n s iv e in s u lin t h e r a p y in s p e c ia l s it ua t io ns\" .) d o s e o f in s u lin t o a d d t o t h e T P N f luid , a s e p a r a t e inf u s io n o f r e g u la r in s u lin c a n b e u s e d in it ia lly . W h e n g lu c o s e s h a v e r e a c h e d g o a l, t he t o t a l d a ily d o s e o f r e g ula r insulin p r o v id e d b y t h e in s u lin d r ip is c a lc u la t e d ; 8 0 p e r c e nt o f t his a m o u nt is a d d e d t o t he T P N f luid a s r e g ula r in s u lin t o b e d e liv e r e d o v e r 2 4 h o u r s . F o r e x a m p le , if t he intr a v e no us insulin inf usio n a t s t e a d y s t a t e w a s s e t a t 1 u n it p e r h o u r (o r 2 4 unit s p e r d a y ), a r o und 8 0 p e r c e nt o f t his a m o unt (2 0 u n it s ) s h o u ld b e a d d e d t o t h e T P N s o lutio n b y t he p h a r m a c y t o b e g iv e n o v e r t he c o ur s e o f t he d a y . T h e a m o u n t o f in s u lin c a n t h e n b e t it r a t e d e v e r y o ne t o t w o d a y s , b a s e d up o n g luc o s e m o n it o r in g . S in c e m o r e f r e q u e n t a d ju s t m e n t s a r e im p r a c t ic a l a nd c o s t ly , t he c o nc ur r e nt use o f r a p id - o r s h o r t - a c t in g in s u lin a s c o r r e c t io n e v e r y s ix ho ur s w ill he lp t o f ine - t une g ly c e m ic m a n a g e m e n t . (S e e 'C o r r e c t io n in s u lin ' a b o v e .) I f T P N is in t e r r u p t e d , m o s t p a t ie n t s w it h t y p e 2 d ia b e t e s c a n b e f o llo w e d w it h c a r e f ul g luc o s e m o n it o r in g . I n s u lin s h o u ld b e a d m inis t e r e d if hy p e r g ly c e m ia o c c ur s . I n p a t ie nts w it h t y p e 1 d ia b e t e s , h y p e r g ly c e m ia w ill o c c u r a nd c a n r e s ult in k e t o s is if a ll insulin is w it hhe ld . T hus, p a t ie n t s w it h t y p e 1 d ia b e t e s r e q u ir e insulin w he n t he T P N is inte r r up t e d . T he a m o unt a nd t y p e o f in s u lin d e p e n d u p o n t h e a n t ic ip a t e d d u r a t io n o f t he inte r r up t io n. B e c a use o f t he p o t e ntia l f o r in a d v e r t e n t d is c o n t in u a t io n o f in s u lin t he r a p y if T P N is inte r r up t e d , s o m e c linic ia ns r e c o m m e nd g iv in g a p o r t io n o f t h e b a s a l in s u lin a s a n inje c t io n (e g , 5 0 p e r c e nt) in p a t ie nts w it h t y p e 1 d ia b e t e s . I n t h e e x a m p le a b o v e (p a t ie nt r e c e iv ing 2 4 unit s o f r e g u la r in s u lin a d a y , 8 0 p e r c e n t o f t h is a m o u n t [1 9 u n it s ] a d d e d t o t he T P N s o lutio n), a p p r o x im a t e ly 1 0 unit s o f r e g ula r insulin c a n b e a d d e d t o t h e T P N s o lu t io n a n d 9 unit s o f N P H , g la r g in e , o r d e t e m ir a d m inis t e r e d a s a b a s a l in je c t io n . T h is a p p r o a c h c a n a ls o b e use d in insulin- r e q u ir ing p a t ie nts w it h t y p e 2 d ia b e t e s . E n t e r a l f e e d i n g s  — I n p a t ie n t s r e c e iv in g c o n t in u o u s e n t e r a l f e e d s , t he t o t a l d a ily d o s e o f in s u lin c o u ld b e a d m in is t e r e d a s b a s a l insulin a lo ne (o nc e - d a ily g la r g ine , d e t e m ir, o r d e g lud e c , o r t w ic e - d a ily d e t e m ir o r N P H ). H o w e v e r, if t he e nte r a l f e e d s a r e une x p e c t e d ly d is c o ntinue d , h y p o g ly c e m ia m a y o c c u r. T h u s , a s a f e r a p p r o a c h m a y b e t o a d m inis t e r a p p r o x im a t e ly 5 0 p e r c e n t o f t h e t o t a l d a ily in s u lin d o s e a s b a s a l insulin a nd 5 0 p e r c e nt a s p r a nd ia l (s ho r t - o r r a p id - a c t in g ) in s u lin , w h ic h is g iv e n e v e r y f o u r (r a p id - a c t ing insulin) t o s ix (s ho r t - a c t ing insulin) h o u r s [3 3 ]. A s im ila r r a t io o f b a s a l- t o - p r a n d ia l insulin c a n b e use d f o r p a t ie nts r e c e iv ing b o lus f e e d s , f o r w h o m t h e p r a n d ia l in s u lin w o uld b e d iv id e d e q u a lly b e f o r e e a c h b o lus f e e d . C o r r e c t io n r a p id - o r s h o r t - a c t in g insulin c a n t he n b e a d m inis t e r e d , a s ne e d e d , w it h t he p r a nd ia l in s u lin (s a m e t y p e ). I n t h o s e r e c e iv ing c y c le d e nte r a l f e e d ing (e g , 8 t o 1 0 ho ur s o v e r nig ht), t he id e a l in s u lin m a y b e N P H , w h ic h h a s a n a c t iv it y p r o f ile s im ila r t o t his d ur a t io n, it s e f f e c t w a ning w h e n t h e f e e d s a r e s t o p p e d . A g a in , c o r r e c t io n r a p id - o r s ho r t - a c t ing insulin c a n t he n b e a d m in is t e r e d a s n e e d e d t o o p t im iz e g ly c e m ic m a na g e m e nt. (S e e 'C o r r e c t io n in s u lin ' a b o v e .) A n o t h e r a p p r o a c h is t o u s e s h o r t - a c t ing insulin a lo ne . T his a p p r o a c h is s up p o r t e d b y t he f in d in g s o f a r a n d o m iz e d t r ia l o f s lid in g - s c a le , r e g u la r in s u lin e v e r y f o u r t o s ix h o u r s a lo n e o r in c o m b in a t io n w it h in s u lin g la r g in e in 5 0 n o n c r it ic a lly ill p a t ie n t s w it h d ia b e t e s r e c e iv ing e nte r a l n u t r it io n [3 4 ]. I n s u lin d o s e s w e r e a d ju s t e d d a ily b a s e d up o n f in g e r s t ic k b lo o d g lu c o s e m e a s u r e m e n t s , a n d N P H in s u lin w a s a d d e d in t he s lid in g - s c a le , r e g u la r insulin g r o up w he n g lu c o s e le v e ls p e r s is t e n t ly e x c e e d e d 1 8 0 m g / d L (1 0 m m o l/ L ). T he r e w e r e no d if f e r e nc e s in a ny g ly c e m ic m e a s u r e s (m e a n s t u d y g lu c o s e , m e a n p e a k o r na d ir g lu c o s e , hy p o g ly c e m ia e v e nts, o r t o t a l d a ily in s u lin d o s e ) b e t w e e n t he t w o g r o up s . H o w e v e r, N P H insulin w a s r e q uir e d in 4 8 p e r c e n t o f s u b je c t s r a n d o m ly a s s ig ne d t o s lid in g - s c a le , r e g u la r insulin. T hus, w he n s lid ing - s c a le , r e g u la r in s u lin a lo n e is c h o s e n a s t he init ia l m a na g e m e nt s t r a t e g y f o r p a t ie nts r e c e iv ing e nte r a l f e e d s , t h e a d d it io n o f b a s a l in s u lin is o f t e n r e q u ir e d t o m a inta in a d e q ua t e g ly c e m ic m a n a g e m e n t . I f t h e e n t e r a l f e e d s (c o n t in u o u s o r b o lu s ) a r e une x p e c t e d ly d is c o ntinue d , a n intr a v e no us 1 0 p e r c e n t d e x t r o s e s o lu t io n , p r o v id ing a s im ila r num b e r o f c a r b o h y d r a t e c a lo r ie s a s w a s b e ing a d m in is t e r e d v ia t h e e n t e r a l f e e d s , s ho uld b e inf u s e d in o r d e r t o p r e v e nt hy p o g ly c e m ia , e s p e c ia lly if t h e b lo o d g lu c o s e c o n c e ntr a t io n f a lls b e lo w 1 0 0 m g / d L . C o n s u l t a t i o n  — M o s t o f t h e t im e , t h e t r e a t m e n t o f hy p e r g ly c e m ia in p a t ie nts w it h d ia b e t e s in t h e s e s t r e s s f u l c ir c u m s t a n c e s c a n b e d o n e b y t he p a t ie nt 's inte r nis t , g e ne r a lis t , o r ho s p it a lis t . H o w e v e r, e a c h c lin ic ia n n e e d s t o d e c id e w he t he r o r no t t he p a t ie nt w o uld b e ne f it f r o m a d d it io n a l a d v ic e ; c o n s u lt a t io n w it h a d ia b e t e s s p e c ia lis t o r e nd o c r ino lo g is t m a y he lp , p a r t ic u la r ly if a c c o m p a n ie d b y a t e a m inc lud in g p e r s o nne l w ho c a n p r o v id e p a t ie nt e d uc a t io n a n d n u t r it io n a l a d v ic e . T h is t e a m a p p r o a c h c a n d e c r e a s e t he p a t ie nt 's le ng t h o f s t a y a s w e ll a s d e c r e a s e t h e t o t a l c o s t o f c a r e [3 5 ,3 6 ]. U s in g t h e h o s p it a liz a t io n t o e n h a nc e t he p a t ie nt 's k n o w le d g e a b o u t t h e d is e a s e a n d t o im p r o v e s e lf - m a na g e m e nt is e nc o ur a g e d . E v a l u a t i o n o f o v e r a l l c a r e  — A b r ie f h o s p it a liz a t io n is a n e x c e lle nt o p p o r t unit y t o a s s e s s o r r e a s s e s s o v e r a ll c a r e in p a t ie n t s w it h d ia b e t e s . I f a p p r o p r ia t e , a t t e ntio n s ho uld b e p a id t o p r e v e n t iv e m e a s u r e s (s u c h a s s m o k ing c e s s a t io n, hy p e r t e nsio n m a na g e m e nt, t r e a t m e nt o f d y s lip id e m ia , a n d a p p r o p r ia t e v a c c ina t io ns) [3 7 ], g ly c e m ic m a n a g e m e n t , a s s e s s m e nt o f p o s s ib le c o m p lic a t io n s o f d ia b e t e s , a nd o v e r a ll p a t ie nt e d u c a t io n. T his a s s e s s m e nt s ho uld le a d t o t h e f o r m u la t io n o f a p la n f o r f u t ur e t r e a t m e n t a f t e r t he p a t ie nt is d is c ha r g e d . (S e e \" O v e r v ie w o f g e n e r a l m e d ic a l c a r e in n o n p r e g na nt a d u lt s w it h d ia b e t e s m e llit us\" .) I n t y p e 2 d ia b e t e s , a n in s u lin r e g im e n m a y no t b e ne c e s s a r y a f t e r t he illne s s r e q uir ing h o s p it a liz a t io n h a s r e s o lv e d . I n a d d it io n, e v e n w he n s uc h a r e g im e n is c o nsid e r e d t o b e t he id e a l o u t p a t ie n t t h e r a p y u p o n d is c ha r g e , t he p a t ie nt m a y no t b e a b le t o c o m p ly s a f e ly w it h t he p r e s c r ib e d in s u lin p r o g r a m , w h ic h r e q u ir e s a d e g r e e o f e d u c a t io n, c o m m it m e nt, a nd s e lf - d is c ip lin e n o t e x h ib it e d b y a ll. T h u s , it is im p o r t a nt t o d e t e r m in e b o t h t he insulin ne e d s a s w e ll a s t h e s e lf - c a r e c a p a c it ie s o f e a c h p a t ie nt p r io r t o d is c ha r g e . O p t im a l r e g im e ns s ho uld b e in d iv id u a liz e d f o r e a c h p a t ie n t . P a t ie n t s m a y r e q u ir e a s ig n if ic a n t d o s e a d ju s t m e n t a f t e r d is c ha r g e f r o m t he ho s p it a l, w hic h is w h y c le a r c o m m u n ic a t io n b e t w e e n t he c linic ia n d e a ling w it h t he a c ute illne s s a nd t he c linic ia n w h o w ill f o llo w t h e p a t ie n t 's d ia b e t e s c a r e a f t e r d is c ha r g e is s o im p o r t a nt. (S e e \" O v e r v ie w o f g e n e r a l m e d ic a l c a r e in n o n p r e g n a nt a d u lt s w it h d ia b e t e s m e llit us\" .) P a t ie n t s f o u n d t o b e n e w ly h y p e r g ly c e m ic d u r ing t im e s o f illne s s m a y a c t ua lly ha v e u n d ia g n o s e d d ia b e t e s . A g ly c o h e m o g lo b in t e s t (A 1 C ) c a n he lp d is c r im ina t e b e t w e e n a c ute , s t r e s s - r e la t e d h y p e r g ly c e m ia a n d p r e e x is t e nt d ia b e t e s . A t a m in im u m , t he s e ind iv id ua ls s ho uld b e r e t e s t e d a s o u t p a t ie n t s u p o n f u ll r e c o v e r y . A d e q ua t e p a t ie nt e d u c a t io n, d is c ha r g e p la nning , a n d t h e im p o r t a n t t r a n s it io n t o t h e o utp a t ie nt a r e na s ho uld b e f a c ilit a t e d b y t he p e r s o nne l d e d ic a t e d t o d ia b e t e s c a r e a t e a c h instit utio n. S O C I ET Y G U I D EL I N E L I N K S L in k s t o s o c ie t y a n d g o v e r n m e n t - s p o nso r e d g u id e lin e s f r o m s e le c t e d c o untr ie s a nd r e g io ns a r o u n d t h e w o r ld a r e p r o v id e d s e p a r a t e ly . (S e e \" S o c ie t y g u id e lin e lin k s : D ia b e t e s m e llit us in a d u lt s \" a n d \" S o c ie t y g u id e lin e lin k s : D ia b e t e s m e llit us in c hild r e n \" .) S U M M A R Y A N D R EC O M M EN D A T I O N S G e n e r a l g o a l s – T h e m a in g o a ls in p a t ie n t s w it h d ia b e t e s ne e d in g ho s p it a liz a t io n a r e t o m in im iz e d is r u p t io n o f t h e m e t a b o lic s t a t e , p r e v e nt a d v e r s e g ly c e m ic e v e nts (e s p e c ia lly h y p o g ly c e m ia ), r e t u r n t h e p a t ie n t t o a s t a b le g ly c e m ic b a la nc e a s q u ic k ly a s p o s s ib le , a nd e n s u r e a s m o o t h t r a n s it io n t o o u t p a t ie nt c a r e . (S e e 'G o a ls in t h e h o s p it a l s e t t in g ' a b o v e .) ● G l y c e m i c g o a l s – F o r m o s t n o n c r it ic a lly ill h o s p it a liz e d p a t ie nts w it h d ia b e t e s , w e s ug g e s t a p r e p r a n d ia l b lo o d g lu c o s e t a r g e t < 1 4 0 m g / d L (7 .8 m m o l/ L ) w it h a ll r a nd o m g luc o s e v a lu e s < 1 8 0 m g / d L (1 0 m m o l/ L ) ( G r a d e 2 C ). (S e e 'N o n c r it ic a lly ill' a b o v e .) ● M o r e s t r in g e n t g o a ls m a y b e a p p r o p r ia t e f o r s t a b le p a t ie nts w it h p r e v io us g o o d g ly c e m ic m a n a g e m e n t , a n d m o r e c o n s e r v a t iv e t a r g e t s s ho uld b e s e t f o r o ld e r p a t ie nts a nd t ho s e w it h s e v e r e c o m o r b id it ie s w h e r e t h e he ig h t e ne d r is k o f hy p o g ly c e m ia m a y o utw e ig h a ny p o t e n t ia l b e n e f it . A C K N O W L ED G M EN T T h e U p To D a t e e d it o r ia l s t a f f a c k n o w le d g e s D a v id M c C u llo c h, M D , w ho c o ntr ib ute d t o e a r lie r v e r s io n s o f t h is t o p ic r e v ie w . U s e o f U p To D a t e is s u b je c t t o t h e Te r m s o f U s e . T y p e 2 d i a b e t e s● P a t ie n t s t r e a t e d b y d ie t a lo n e u s u a lly ne e d no s p e c if ic a ntihy p e r g ly c e m ic t he r a p y . F r e q u e n t b lo o d g lu c o s e m o n it o r in g is w a r r a nte d t o p r e v e nt s e r io us hy p e r g ly c e m ia f r o m b e in g u n r e c o g n iz e d . (S e e 'D ie t - t r e a t e d p a t ie n t s ' a b o v e .) • P a t ie n t s t r e a t e d w it h o r a l a n t ih y p e r g ly c e m ic d r ug s o r inje c t a b le g lu c a g o n- lik e p e p t id e 1 (G L P - 1 )- b a s e d t h e r a p ie s c a n o c c a s io na lly c o ntinue t he ir usua l d r ug r e g im e n in s o m e c ir c u m s t a n c e s (p a t ie n t e a t in g , g lu c o s e w e ll m a na g e d , a nd no c o ntr a ind ic a t io n t o o r a l a g e n t s ) ( a lg o r it h m 1 ). H o w e v e r, if b lo o d g lu c o s e le v e ls a r e p o o r ly m a na g e d w it h t he u s u a l o r a l a g e n t s o r if t h e p a t ie n t is no t e a t ing , d r ug t he r a p y s ho uld b e d is c o ntinue d a n d in s u lin in it ia t e d ( a lg o r it h m 2 ). (S e e 'P a t ie n t s t r e a t e d w it h o r a l a g e n t s o r in je c t a b le G L P - 1 - b a s e d t h e r a p ie s ' a b o v e .) • I n s u lin t h e r a p y s h o u ld b e c o n t in u e d in a ll p a t ie nts a lr e a d y t a k ing it t o m a inta in a r e a s o n a b ly c o n s t a n t b a s a l le v e l o f c ir c ula t ing insulin ( a lg o r it h m 1 a n d a lg o r it h m 2 ). (S e e 'P a t ie n t s t r e a t e d w it h in s u lin ' a b o v e .) • T y p e 1 d i a b e t e s● P a t ie n t s w it h t y p e 1 d ia b e t e s r e q u ir e insulin a t a ll t im e s , w he t he r o r no t t he y a r e e a t in g . I n s u lin c a n b e g iv e n e it h e r s ub c u t a ne o usly o r intr a v e no usly . F o r s ub c uta ne o us in s u lin , s lid in g s c a le s s h o u ld n e v e r b e use d a s t he s o le insulin. O p t im a lly , b a s a l insulin (g la r g in e , d e t e m ir, d e g lu d e c , o r n e utr a l p r o t a m in e ha g e d o r n [N P H ]) s ho uld b e c o m b in e d w it h p r a n d ia l a n d c o r r e c t io n insulin (t y p ic a lly , r a p id - a c t ing insulin) ( a lg o r it h m 1 a n d a lg o r it h m 2 ). (S e e 'P a t ie n t s w it h t y p e 1 d ia b e t e s ' a b o v e .) • W h e n in t r a v e n o u s in s u lin is g iv e n , o nc e t he b lo o d g lu c o s e le v e ls a r e in g o a l r a ng e , g lu c o s e (a s d e x t r o s e o r in t o t a l p a r e n t e r a l n u t r it io n [T P N ]) s h o u ld b e a d m in is t e r e d t o p r e v e n t c a t a b o lis m . B lo o d g lu c o s e s ho uld b e m e a s ur e d f r e q u e ntly (e v e r y o ne t o t w o h o u r s in p a t ie n t s r e c e iv in g a n in s u lin inf u s io n). (S e e 'I n s u lin in f u s io n ' a b o v e .) • R E F E R E N C E S 1 . A h m a n n A . C o m p r e h e n s iv e m a n a g e m e nt o f t he ho s p it a liz e d p a t ie nt w it h d ia b e t e s . E n d o c r in o lo g is t 1 9 9 8 ; 8 :2 5 0 . 2 . M o s s S E , K le in R , K le in B E . R is k f a c t o r s f o r ho s p it a liz a t io n in p e o p le w it h d ia b e t e s . A r c h I n t e r n M e d 1 9 9 9 ; 1 5 9 :2 0 5 3 . 3 . C h a n e y M A , N ik o lo v M P, B la k e m a n B P, B a k ho s M . A t t e m p t ing t o m a inta in no r m o g ly c e m ia d u r in g c a r d io p u lm o n a r y b y p a s s w it h insulin m a y init ia t e p o s t o p e r a t iv e hy p o g ly c e m ia . A n e s t h A n a lg 1 9 9 9 ; 8 9 :1 0 9 1 . 4 . N a s r a w a y S A Jr. S it t in g o n t h e h o r n s o f a d ile m m a : a v o id in g s e v e r e hy p o g ly c e m ia w hile p r a c t ic in g t ig h t g ly c e m ic c o n t r o l. C r it C a r e M e d 2 0 0 7 ; 3 5 :2 4 3 5 . 5 . T u r c h in A , M a t h e n y M E , S h u b in a M , e t a l. H y p o g ly c e m ia a nd c linic a l o utc o m e s in p a t ie nts w it h d ia b e t e s h o s p it a liz e d in t h e g e ne r a l w a r d . D ia b e t e s C a r e 2 0 0 9 ; 3 2 :1 1 5 3 . 6 . C le m e n t S , B r a it h w a it e S S , M a g e e M F, e t a l. M a na g e m e nt o f d ia b e t e s a nd hy p e r g ly c e m ia in h o s p it a ls . D ia b e t e s C a r e 2 0 0 4 ; 2 7 :5 5 3 . 7 . U m p ie r r e z G E , I s a a c s S D , B a z a r g a n N , e t a l. H y p e r g ly c e m ia : a n ind e p e nd e nt m a r k e r o f in- h o s p it a l m o r t a lit y in p a t ie n t s w it h u nd ia g n o s e d d ia b e t e s . J C lin E nd o c r ino l M e t a b 2 0 0 2 ; 8 7 :9 7 8 . 8 . P o m p o s e lli JJ, B a x t e r JK 3 r d , B a b in e a u T J, e t a l. E a r ly p o s t o p e r a t iv e g lu c o s e c o ntr o l p r e d ic t s n o s o c o m ia l in f e c t io n r a t e in d ia b e t ic p a t ie nts. JP E N J P a r e nte r E nte r a l N utr 1 9 9 8 ; 2 2 :7 7 . 9 . U m p ie r r e z G E , H e llm a n R , K o r y t k o w s k i M T , e t a l. M a na g e m e nt o f hy p e r g ly c e m ia in h o s p it a liz e d p a t ie n t s in n o n - c r it ic a l c a r e s e t t ing : a n e nd o c r ine s o c ie t y c linic a l p r a c t ic e g u id e lin e . J C lin E n d o c r in o l M e t a b 2 0 1 2 ; 9 7 :1 6 . 1 0 . A m e r ic a n D ia b e t e s A s s o c ia t io n P r o f e s s io na l P r a c t ic e C o m m it t e e . 1 6 . D ia b e t e s C a r e in t he H o s p it a l: S t a n d a r d s o f C a r e in D ia b e t e s - 2 0 2 4 . D ia b e t e s C a r e 2 0 2 4 ; 4 7 :S 2 9 5 . 1 1 . H ir s c h I B , P a a u w D S , B r u n z e ll J. I n p a t ie nt m a na g e m e nt o f a d u lt s w it h d ia b e t e s . D ia b e t e s C a r e 1 9 9 5 ; 1 8 :8 7 0 . 1 2 . Ja c o b e r S J, S o w e r s JR . A n u p d a t e o n p e r io p e r a t iv e m a na g e m e nt o f d ia b e t e s . A r c h I nte r n M e d 1 9 9 9 ; 1 5 9 :2 4 0 5 . 1 3 . I n z u c c h i S E . C lin ic a l p r a c t ic e . M a n a g e m e nt o f hy p e r g ly c e m ia in t he ho s p it a l s e t t ing . N E ng l J M e d 2 0 0 6 ; 3 5 5 :1 9 0 3 . 1 4 . S p a n a k is E K , U r r u t ia A , G a lin d o R J, e t a l. C o ntinuo us G luc o s e M o n it o r ing - G uid e d I nsulin A d m in is t r a t io n in H o s p it a liz e d P a t ie nts W it h D ia b e t e s : A R a nd o m iz e d C linic a l T r ia l. D ia b e t e s C a r e 2 0 2 2 ; 4 5 :2 3 6 9 . 1 5 . F o r t m a n n A L , S p ie r lin g B a g s ic S R , Ta la v e r a L , e t a l. G luc o s e a s t he F if t h V it a l S ig n: A R a n d o m iz e d C o n t r o lle d T r ia l o f C o n t inuo us G luc o s e M o n it o r ing in a N o n- I C U H o s p it a l S e t t in g . D ia b e t e s C a r e 2 0 2 0 ; 4 3 :2 8 7 3 . 1 6 . To r r e s R o ld a n V D , U r t e c h o M , N a y f e h T , e t a l. A S y s t e m a t ic R e v ie w S up p o r t ing t he E n d o c r in e S o c ie t y G u id e lin e s : M a n a g e m e nt o f D ia b e t e s a nd H ig h R is k o f H y p o g ly c e m ia . J C lin E n d o c r in o l M e t a b 2 0 2 3 ; 1 0 8 :5 9 2 . 1 7 . M c C a ll A L , L ie b D C , G ia n c h a n d a n i R , e t a l. M a na g e m e nt o f I nd iv id ua ls W it h D ia b e t e s a t H ig h R is k f o r H y p o g ly c e m ia : A n E n d o c r ine S o c ie t y C linic a l P r a c t ic e G uid e line . J C lin E n d o c r in o l M e t a b 2 0 2 3 ; 1 0 8 :5 2 9 . 1 8 . Q u e a le W S , S e id le r A J, B r a n c a t i F L . G ly c e m ic c o ntr o l a nd s lid in g s c a le insulin use in m e d ic a l in p a t ie n t s w it h d ia b e t e s m e llit u s . A r c h I nte r n M e d 1 9 9 7 ; 1 5 7 :5 4 5 . 1 9 . S h e t t y S , I n z u c c h i S E , G o ld b e r g P A , e t a l. A d a p t ing t o t he ne w c o nse nsus g uid e line s f o r m a n a g in g h y p e r g ly c e m ia d u r in g c r it ic a l illne s s : t he up d a t e d Y a le insulin inf usio n p r o t o c o l. E n d o c r P r a c t 2 0 1 2 ; 1 8 :3 6 3 . 2 0 . G o ld b e r g P A , S ie g e l M D , S h e r w in R S , e t a l. I m p le m e n t a t io n o f a s a f e a nd e f f e c t iv e insulin in f u s io n p r o t o c o l in a m e d ic a l in t e nsiv e c a r e unit . D ia b e t e s C a r e 2 0 0 4 ; 2 7 :4 6 1 . 2 1 . Y a m a s h it a S , N g E , B r o m m e c k e r F, e t a l. I m p le m e n t a t io n o f t he g lu c o m m a nd e r m e t ho d o f a d ju s t in g in s u lin in f u s io n s in c r it ic a lly ill p a t ie nts. C a n J H o s p P ha r m 2 0 1 1 ; 6 4 :3 3 3 . 2 2 . Jo h n S M , W a t e r s K L , Jiv a n i K . E v a lu a t ing t he I m p le m e n t a t io n o f t he E nd o To o l G ly c e m ic C o n t r o l S o f t w a r e S y s t e m . D ia b e t e s S p e c t r 2 0 1 8 ; 3 1 :2 6 . 2 3 . U m p ie r r e z G E , G ia n c h a n d a n i R , S m ile y D , e t a l. S a f e t y a nd e f f ic a c y o f s it a g lip t in t he r a p y f o r t h e in p a t ie n t m a n a g e m e n t o f g e n e r a l m e d ic ine a nd s ur g e r y p a t ie nts w it h t y p e 2 d ia b e t e s : a p ilo t , r a n d o m iz e d , c o n t r o lle d s t u d y . D ia b e t e s C a r e 2 0 1 3 ; 3 6 :3 4 3 0 . 2 4 . V e lla n k i P, R a s o u li N , B a ld w in D , e t a l. G ly c a e m ic e f f ic a c y a nd s a f e t y o f lina g lip t in c o m p a r e d t o a b a s a l- b o lu s in s u lin r e g im e n in p a t ie nts w it h t y p e 2 d ia b e t e s und e r g o ing no n- c a r d ia c s u r g e r y : A m u lt ic e n t r e r a n d o m iz e d c linic a l t r ia l. D ia b e t e s O b e s M e t a b 2 0 1 9 ; 2 1 :8 3 7 . 2 5 . U m p ie r r e z G E , H o r T , S m ile y D , e t a l. C o m p a r is o n o f inp a t ie nt insulin r e g im e ns w it h d e t e m ir p lu s a s p a r t v e r s u s n e u t r a l p r o t a m ine ha g e d o r n p lu s r e g u la r in m e d ic a l p a t ie nts w it h t y p e 2 d ia b e t e s . J C lin E n d o c r in o l M e t a b 2 0 0 9 ; 9 4 :5 6 4 . 2 6 . U m p ie r r e z G E , S m ile y D , Z is m a n A , e t a l. R a nd o m iz e d s t ud y o f b a s a l- b o lus insulin t he r a p y in t h e in p a t ie n t m a n a g e m e n t o f p a t ie n t s w it h t y p e 2 d ia b e t e s (R A B B I T 2 t r ia l). D ia b e t e s C a r e 2 0 0 7 ; 3 0 :2 1 8 1 . 2 7 . S c h o e f f le r JM , R ic e D A , G r e s h a m D G . 7 0 / 3 0 insulin a lg o r it hm v e r s us s lid ing s c a le insulin. A n n P h a r m a c o t h e r 2 0 0 5 ; 3 9 :1 6 0 6 . 2 8 . U m p ie r r e z G E , S m ile y D , Ja c o b s S , e t a l. R a nd o m iz e d s t ud y o f b a s a l- b o lus insulin t he r a p y in t h e in p a t ie n t m a n a g e m e n t o f p a t ie n t s w it h t y p e 2 d ia b e t e s und e r g o ing g e ne r a l s ur g e r y (R A B B I T 2 s u r g e r y ). D ia b e t e s C a r e 2 0 1 1 ; 3 4 :2 5 6 . 2 9 . U m p ie r r e z G E , S m ile y D , H e r m a y e r K , e t a l. R a nd o m iz e d s t ud y c o m p a r ing a B a s a l- b o lus w it h a b a s a l p lu s c o r r e c t io n in s u lin r e g im e n f o r t he ho s p it a l m a na g e m e nt o f m e d ic a l a nd s u r g ic a l p a t ie n t s w it h t y p e 2 d ia b e t e s : b a s a l p lu s t r ia l. D ia b e t e s C a r e 2 0 1 3 ; 3 6 :2 1 6 9 . 3 0 . B a lla n i P, T r a n M T , N a v a r M D , D a v id s o n M B . C linic a l e x p e r ie nc e w it h U - 5 0 0 r e g ula r insulin in o b e s e , m a r k e d ly in s u lin - r e s is t a n t t y p e 2 d ia b e t ic p a t ie nts. D ia b e t e s C a r e 2 0 0 6 ; 2 9 :2 5 0 4 . 3 1 . h t t p :/ / w w w .f d a .g o v / D r u g s / D r u g S a f e t y / u c m 5 1 0 3 1 8 .h t m (A c c e s s e d o n S e p t e m b e r 2 8 , 2 0 1 6 ). 3 2 . B a lly L , T h a b it H , H a r t n e ll S , e t a l. C lo s e d - L o o p I nsulin D e liv e r y f o r G ly c e m ic C o ntr o l in N o n c r it ic a l C a r e . N E n g l J M e d 2 0 1 8 ; 3 7 9 :5 4 7 . 3 3 . W e s o r ic k D , O 'M a lle y C , R u s h a k o f f R , e t a l. M a na g e m e nt o f d ia b e t e s a nd hy p e r g ly c e m ia in t h e h o s p it a l: a p r a c t ic a l g u id e t o s ub c u t a ne o us insulin use in t he no n- c r it ic a lly ill, a d ult p a t ie n t . J H o s p M e d 2 0 0 8 ; 3 :1 7 . 3 4 . K o r y t k o w s k i M T , S a la t a R J, K o e r b e l G L , e t a l. I nsulin t he r a p y a nd g ly c e m ic c o ntr o l in h o s p it a liz e d p a t ie n t s w it h d ia b e t e s d u r ing e nte r a l nutr it io n t he r a p y : a r a nd o m iz e d c o n t r o lle d c lin ic a l t r ia l. D ia b e t e s C a r e 2 0 0 9 ; 3 2 :5 9 4 . 3 5 . L e v e t a n C S , S a la s JR , W ile t s I F, Z u m o f f B . I m p a c t o f e nd o c r ine a nd d ia b e t e s t e a m c o n s u lt a t io n o n h o s p it a l le n g t h o f s t a y f o r p a t ie nts w it h d ia b e t e s . A m J M e d 1 9 9 5 ; 9 9 :2 2 . 3 6 . K o p r o s k i J, P r e t t o Z , P o r e t s k y L . E f f e c t s o f a n inte r v e ntio n b y a d ia b e t e s t e a m in ho s p it a liz e d p a t ie n t s w it h d ia b e t e s . D ia b e t e s C a r e 1 9 9 7 ; 2 0 :1 5 5 3 . 3 7 . S m it h S A , P o la n d G A . U s e o f in f lu e nz a a nd p n e um o c o c c a l v a c c ine s in p e o p le w it h d ia b e t e s . D ia b e t e s C a r e 2 0 0 0 ; 2 3 :9 5 . To p ic 1 7 7 0 V e r s io n 4 1 .0 G R A P H I C S H y p e r g l y c e m i a t r e a t m e n t f o r h o s p i t a l i z e d p a t i e n t s e a t i n g a n o r m a l d i e t P r o p o s e d a lg o r it h m f o r m a n a g e m e n t o f d ia b e t e s a n d h y p e r g ly c e m ia in t h e n o n c r it ic a l c a r e s e t t in g . D M : d ia b e t e s m e llit u s ; G L P - 1 : g lu c a g o n - lik e p e p t id e - 1 ; B G : b lo o d g lu c o s e ; D / C : d is c o n t in u e . R e p r o d u c e d w it h p e r mis s io n f r o m: I n z u c c h i S E . D ia b e t e s f a c t s a n d g u id e lin e s . Y a le D ia b e t e s C e n t e r , 2 0 1 1 . C o p y r ig h t © 2 0 1 1 . G r a p h ic 7 2 6 2 7 V e r s io n 5 .0 H y p e r g l y c e m i a t r e a t m e n t f o r h o s p i t a l i z e d p a t i e n t s r e c e i v i n g n o t h i n g b y m o u t h P r o p o s e d a lg o r it h m f o r m a n a g e m e n t o f d ia b e t e s a n d h y p e r g ly c e m ia in t h e n o n c r it ic a l c a r e s e t t in g . N P O : n il p e r o s (n o t h in g b y m o u t h ); D M : d ia b e t e s m e llit u s : G L P - 1 : g lu c a g o n - lik e p e p t id e - 1 ; B G : b lo o d g lu c o s e ; I V : in t r a v e n o u s . * A d ju s t e d b a s e d o n c u r r e n t d e g r e e o f h y p e r g ly c e m ia ; c o n s id e r m o d e s t ( 2 0 - 2 5 % ) d o s e r e d u c t io n if t ig h t ly c o n t r o lle d o n a d m is s io n , t o b e c o n s e r v a t iv e . R e p r o d u c e d w it h p e r mis s io n f r o m: I n z u c c h i S E . D ia b e t e s f a c t s a n d g u id e lin e s . Y a le D ia b e t e s C e n t e r , 2 0 1 1 . C o p y r ig h t © 2 0 1 1 . G r a p h ic 5 9 8 2 2 V e r s io n 4 .0 ","libVersion":"0.3.1","langs":""}